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ABSTRACT 
 
Mariam Shamszad 
 
Highly Selective Auxiliary-Mediated Acetate Aldol Additions and Progress 
Towards the Total Synthesis of (−)-Brevenal 
 
(Under the direction of Michael T. Crimmins) 
 
 
 
 The development of a highly selective acetate aldol addition using 
chlorotitanium enolates of novel mesityl-substituted N-acetyloxazolidinethione 
and N-acetylthiazolidinethione auxiliaries is herein described. This method 
proceeds in high yields and diastereoselectivity for aliphatic, aromatic, α, β-
unsaturated, and non-racemic aldehydes, efficiently generating the β-
hydroxycarbonyl subunit, prevalent in polyketide-derived natural products. 
 Efforts towards the total synthesis of the marine pentacyclic polyether, (−)-
brevenal, are also described. (−)-Brevenal has been found to counteract the toxic 
effects of the brevetoxins, a family of molecules also produced by Karenia brevis, 
alleviating respiratory distress. A highly convergent route to (−)-brevenal is herein 
illustrated in which a Horner-Wadsworth-Emmons reaction is used to couple two 
key complex cyclic ether fragments. In addition, an asymmetric glycolate 
alkylation/ring-closing metathesis strategy has been employed to synthesize two 
of the five rings. 
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 Chapter 1 
Development of a Highly Selective Acetate Aldol Addition 
 
 On the basis of the seminal report of Evans and coworkers on the use of 
boron enolates of N-acyloxazolidinones for highly diastereoselective syn-
propionate aldol additions,1 auxiliary-mediated asymmetric aldol additions have 
become one of the most valuable methods for the construction of carbon-carbon 
bonds.2-4 In particular, the asymmetric aldol addition has played a significant role 
in the synthesis of the β-hydroxycarbonyl subunit, prevalent in polyketide-derived 
natural products.5 While high stereocontrol of this reaction can be achieved 
through the use of chiral ligands and chiral catalysts, auxiliary-based aldol 
additions remain a valuable and widely employed method. Although many 
auxiliaries have been developed to promote the asymmetric propionate aldol 
addition, minimal diastereoselectivity is attained when these auxiliaries are 
applied to the acetate aldol addition. This chapter will outline the recent advances 
we have made in the development of highly selective acetate aldol additions 
using the chlorotitanium enolates of mesityl-substituted N-acetyloxazolidinethione 
and N-acetylthiazolidinethione auxiliaries (Figure 1.1). 
 
 2 
 
 
 
 
 
A. Background 
 (i) Asymmetric Aldol Additions Using Chiral Auxiliaries 
 The chiral auxiliary-mediated asymmetric aldol addition has been the 
focus of extensive research over the years, becoming an invaluable method in 
organic synthesis. In 1981, the pioneering studies of Evans and coworkers 
established that the use of boron enolates of N-acyloxazolidinones resulted in a 
highly diastereoselective propionate aldol addition, via a dipole-minimized 
transition state (Table 1.1).1 While this dibutylboron triflate mediated aldol 
addition is a widely used and well accepted method, it suffers from several 
limitations: 1) oxazolidinones can be difficult to remove on certain substrates, 2) 
dibutylboron triflate 
is more expensive 
than other Lewis 
acids and must be 
freshly distilled prior 
to use, and 3) an 
extra step of 
oxidative workup is required to hydrolyze the dibutylboronates. 
>99:188%PhCHO3
>99:175%(CH3)2CHCH2CHO2
>99:178%(CH3)2CHCHO1
drYieldAldehydeEntry
 3 
 Since this seminal work, intensive research has led to the development of 
a large number of chiral auxiliaries that give rise to syn- or anti-propionate aldol 
products in high yields and excellent diastereoselectivities. In particular, previous 
work in the Crimmins laboratory has led to the development of highly 
diastereoselective auxiliary-based propionate aldol additions6-8 and anti-selective 
glycolate aldol additions9 through the use of chlorotitanium enolates of N-
acyloxazolidinethiones and N-acylthiazolidinethiones. With respect to the 
propionate aldol addition, the “Evans” syn and “non-Evans” syn products can 
both be obtained from the same enantiomer of the chiral auxiliary simply by 
altering the nature and stoichiometry of the Lewis acid and amine base (Figure 
1.2). Specifically, one equivalent each of titanium tetrachloride, (−)-sparteine as 
the base, and N-methyl-2-pyrolidinone (NMP), provides “Evans” syn aldol 
adducts with selectivities ranging from 97:3 to >99:1. The “non-Evans” syn aldol 
adducts are attainable with oxazolidinethiones and thiazolidinethiones by altering 
the stoichiometry of titanium tetrachloride and/or the amine base. The difference 
in facial selectivity in the aldol additions is believed to be the result of a switch 
 4 
between chelated and nonchelated transition states, in which the presence of 
NMP breaks chelation between the sulfur of the thiocarbonyl of the auxiliary and 
titanium, leading to a dipole-minimized, non-chelated transition state, giving rise 
to the “Evans” syn aldol adduct (Figure 1.3). Without NMP, the reaction proceeds 
through a chelated transition state, giving rise to “non-Evans” syn aldol adducts. 
The auxiliaries can then be removed reductively or cleaved by a nucleophilic acyl 
substitution to reveal the β-hydroxycarbonyl subunit. 
 
 
 
 
 
 
(ii) Previous Advances in the Asymmetric Acetate Aldol Addition 
 While the development of the asymmetric propionate aldol addition has 
reached high levels of success over the years, the advancement of an analogous 
method towards an auxiliary-based asymmetric acetate aldol addition has proven 
to be a more elusive task; the same auxiliaries that have been successful for 
other types of aldol additions result in reduced diastereoselectivity for the acetate 
aldol addition, particularly for aliphatic aldehydes. For example, the dibutylboryl 
enolate of Evans’ valine-derived acetyl oxazolidinone gives a 52:48 ratio of 
diastereomers with isobutyraldehyde and a 72:28 ratio with acetaldehyde when 
used for acetate aldol additions.1 A number of chiral auxiliaries have been 
 5 
developed in an effort to improve the diastereoselectivity of acetate-type aldol 
additions involving the use of tin,10 lithium,11,12 boron,13,14 and titanium15,16,17,18 
chiral acetate enolates (Figure 1.4). These methods, however, suffer from 
several limitations: 1) the necessity of expensive reagent and/or metals, 2) low 
reaction temperature (lower than -100 °C), 3) narro w substrate scope, 4) lengthy 
preparation of the auxiliary, and 5) modest diastereoselectivity. These 
shortcomings have thereby limited the utility of the asymmetric acetate aldol 
addition in synthetic applications. To date, the highly hindered auxiliaries recently 
advanced by Phillips17  and Sammakia18 provide the most consistent high levels 
of diastereoselectivity. 
   
 
 
 
 
 
 
 
 
B. Asymmetric Acetate Aldol Additions Using Mesityl-Substituted 
Auxiliaries 
  
 The diminished diastereoselectivity of the acetate aldol addition, in 
comparison to the high levels of diastereoselectivity attainable for propionate 
 6 
aldol additions, has been attributed to the lack of substitution at the α-carbon of 
the enolate, which is believed to function as an important stereocontrol element. 
In the propionate aldol addition, it is believed that a chair transition state is 
preferred over the boat transition state due to the disfavored interactions 
between the methyl group of the α-carbon of the enolate and the hydrogen of the 
aldehyde and between the hydrogen of the α-carbon and the “R” group of the 
aldehyde (Figure 1.5). In the case of the acetate aldol addition, because there is 
no longer a methyl group present at the α-carbon, the preference for one 
transition state over the other no longer exists, thereby causing a lack of 
stereocontrol in the reaction.  
 
 In an attempt to overcome this issue, we have investigated more sterically 
encumbered chiral auxiliaries to improve the selectivity of acetate aldol additions 
using the chlorotitanium enolates of mesityl-substituted N-acetyloxazolidinethione 
and N-acetylthiazolidinethione chiral auxiliaries. Mesityl-substituted auxiliaries 
were chosen due to the restricted rotational freedom about the bond between the 
aromatic ring and the benzylic carbon.19,20 This was expected to compensate for 
 7 
the lack of substitution at the α-carbon and lead to a more ordered transition 
state, thereby increasing the diastereoselectivity.  
(i) Acetate Aldol Additions Using a Mesityl-Substituted Oxazolidinethione 
 Before investigating an enantioselective synthetic route to the desired 
mesityl-substituted N-acetyloxazolidinethione, a racemic version was first 
developed to test the auxiliary’s performance in the acetate aldol addition. 
Dihydroxylation of commercially available trimethylstyrene gave diol 1, which, 
upon exposure to Ritter conditions21 followed by hydrolysis, afforded amino 
alcohol 2 (Scheme 1.1). Treatment with thiophosgene and triethylamine led to 
the formation of oxazolidinethione 3, and subsequent exposure to acetyl chloride 
and triethylamine provided the desired N-acetyloxazolidinethione 4. 
 
 
 
 
 
 
  
 With the acetylated auxiliary in hand, studies on the acetate aldol addition 
commenced. Initially, N-acetyloxazolidinethione 4 was treated with titanium 
tetrachloride (1 equiv) and diisopropylethylamine (1 equiv) followed by addition of 
aldehyde (1.2 equiv). A variety of aldehydes were screened under these reaction 
conditions, providing moderate yields and high diastereomeric ratios for several 
 8 
aldehydes (Table 1.2). While high selectivities were obtained for several 
aldehydes (entries 3-6), the diastereomeric ratios were not consistent for all 
aldehydes screened. In addition, it was necessary to improve upon the modest 
yields. By modifying the stoichiometry of titanium tetrachloride (2 equiv) and 
diisopropylethylamine (2 equiv), higher yields and consistently high 
diastereoselectivities were obtained (Table 1.2). The mesityl-substituted auxiliary 
performed well with aromatic aldehydes (entry 6), aliphatic aldehydes (2-5), and 
α, β-unsaturated aldehydes (entry 1). Under these optimized conditions, the 
yields ranged from 71% to 86% with diastereomeric ratios of 92:8 to 99:1. An 
added benefit to the high diastereoselectivities was the ability to cleanly separate 
the diastereomers via column chromatography. 
  
  
 
  
  
 
  
 With a successful diastereoselective acetate aldol addition in hand, 
investigations into an enantioselective synthetic route of the auxiliary 
commenced. It was initially proposed that an efficient route for the synthesis of 
96:486%96:442%PhCHO6
99:184%92:860%EtCHO5
92:886%94:661%(CH3)2CHCHO4
94:686%94:677%n-PrCHO3
95:577%76:2461%(CH3)2CHCH2CHO2
94:671%88:1266%PhCH=CHCHO1
drYielddrYieldAldehydeEntry
2.0 eq TiCl4
2.0 eq (i-Pr)2NEt
1.0 eq TiCl4
1.0 eq (i-Pr)2NEt
 9 
the desired N-acetyloxazolidinethione would begin with a Sharpless asymmetric 
aminohydroxylation (SAA)22 of trimethylstyrene to form the Boc-protected amino 
alcohol 6 (Scheme 1.2). Subsequent removal of the Boc group, formation of the 
auxiliary and ultimate acylation would lead to the formation of the desired (S)-N-
acetyloxazolidinethione 9 in four steps. The SAA of trimethylstyrene, however, 
was sluggish and the highest yield obtained, despite various optimization 
attempts, did not exceed 21%. This result is consistent with the findings of 
O’Brien and coworkers, who determined that the presence of ortho-substituents 
is detrimental to the SAA of styrene derivatives.23 
  
 Since the SAA approach to the desired N-acetyloxazolidinethione was 
unsuccessful, efforts were then focused on the employment of tert-
butylsulfinamide methodology developed by Ellman (Scheme 1.3).24-26 Imine 11 
was prepared via the copper sulfate-mediated condensation of (R)-(+)-2-methyl-
2-propanesulfinamide 10 and (4-methoxybenzyloxy)acetaldehyde. Addition of 
mesitylmagnesium bromide to imine 11 afforded a single diastereomer of the 
protected amino alcohol 12. The addition of the mesityl group occurs from the Re 
 10 
face of the imine due to coordination between magnesium and the PMB ether.25 
Concomitant acid-catalyzed removal of the sulfinyl and PMB groups provided 
amino alcohol 13. Finally, formation of the auxiliary followed by acylation yielded 
(R)-N-acetyloxazolidinethione 14. The stereochemistry of oxazolidinone 14 was 
confirmed by X-ray crystallography (Figure 1.6). 
  
 
 
  
 
 As with the racemic variant of the acylated auxiliary, enolization of 14 with 
titanium tetrachloride (2 equiv) and diisopropylethylamine (2 equiv), followed by 
addition of the aldehyde (1.2 equiv), resulted in a highly diastereoselective 
acetate aldol addition across a wide range of aldehydes (Table 1.3). Once again, 
this protocol was amenable to aliphatic, aromatic, and α, β-unsaturated 
aldehydes. The stereochemistry of the addition was determined by reductive 
 11 
cleavage of the adduct obtained in entry 4 to afford (S)-4-methyl-pentane-1,3-diol, 
as confirmed by polarimetry.27 
 
 
 
 
 
 
 
 
 
(ii) Acetate Aldol Additions Using a Mesityl-Substituted Thiazolidinethione 
 With a highly diastereoselective acetate aldol addition using a mesityl-
substituted N-acetyloxazolidinethione in hand, efforts then shifted towards the 
formation of a mesityl-substituted N-acetylthiazolidinethione. A major advantage 
of using thiazolidinethiones over oxazolidinethiones lies in the ease with which 
thiazolidinethiones can be directly converted to a variety of functional groups, 
such as aldehydes, amides, β-ketophosphonates, and β-ketoesters, whereas 
conversions of oxazolidinethiones are limited.8,28 All attempts, however, to 
convert amino alcohol 13 into mesityl-substituted thiazolidinethione 17 using 
LeCorre’s standard protocol29 were unsuccessful (Scheme 1.4); the reaction 
afforded a mixture of thiazolidinethione 17 and oxazolidinethione 14, with 14 
being the major product, and the products formed were susceptible to 
96:489%PhCHO6
95:578%EtCHO5
94:688%(CH3)2CHCHO4
95:585%n-PrCHO3
96:484%(CH3)2CHCH2CHO2
93:772%PhCH=CHCHO1
dr (15:16)YieldAldehydeEntry
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decomposition in the reaction mixture. 
Attempts to optimize the reaction included 
1) lowering the reaction temperature by 
refluxing in solvents with lower boiling 
points, 2) increasing the amount of carbon disulfide to favor thiazolidinethione 
formation, and 3) adding solvents, such as dioxane, to prevent the 
oxazolidinethione intermediate from precipitating out of the reaction mixture. 
Despite these efforts, the highest yield of thiazolidinethione 17 obtained was only 
40%. 
 Because oxazolidinethione 14 was the major product obtained under 
LeCorre’s conditions from amino alcohol 13, investigations into the formation of 
thiazolidinethione 17 from an amino thiol instead of an amino alcohol were 
explored (Scheme 1.5). Imine 18 was generated from the condensation of (R)-
(+)-2-methyl-2-propanesulfinamide 10 and (4-methoxybenzylthio)acetaldehyde. 
Treatment with mesitylmagnesium bromide gave protected amino thiol 19 as a 
single diastereomer. At this point, concomitant deprotection of the sulfinyl and 
 13 
PMB groups was attempted, however, none of the conditions examined were 
able to remove the PMB group. Another difficulty with this route was the 
preparation of (4-methoxybenzylthio)acetaldehyde due to its instability. For these 
reasons, further investigations into this route were abandoned. 
 Next, investigations into the formation of the desired mesityl-substituted 
thiazolidinethione from an amino halide were explored (Scheme 1.6). 
Condensation of (R)-(+)-2-methyl-2-propanesulfinamide 10 with 
chloroacetaldehyde provided imine 22, which upon exposure to 
mesitylmagnesium bromide provided sulfinyl-protected amino halide 23 as a 
single diastereomer. It is important to note that, in this case, addition of the 
mesityl group occurs from the Si face of the imine due to the lack of coordination 
between magnesium and chlorine.25 Removal of the sulfinyl group under acidic 
conditions then afforded the amino halide, which was successfully converted to 
the desired mesityl-substituted thiazolidinethione 24 using LeCorre’s protocol. 
Treatment with acetyl chloride and sodium hydride then gave mesityl-substituted 
N-acetylthiazolidinethione 25. 
 14 
 Because the Grignard 
addition of mesitylmagnesium 
bromide provided a single 
diastereomer of the sulfinyl-
protected amino halide, this 
reaction could be quenched with hydrochloric acid, neutralized, and directly 
treated with carbon disulfide and aqueous potassium hydroxide to directly access 
thiazolidinethione 24, shortening the reaction sequence (Scheme 1.7).  
 Enolization of N-acetylthiazolidinethione 25 under optimized reaction 
conditions (1.1 equiv titanium tetrachloride and 1.1 equiv diisopropylethylamine) 
followed by addition of the aldehyde (1.0 equiv) resulted in highly 
diastereoselective acetate aldol additions (Table 1.4). It was found that when 
excess aldehyde was used in these reactions, a decrease in diastereoselectivity 
was observed. Aliphatic, aromatic, and α, β-saturated aldehydes were amenable 
to this procedure and all diastereomers prepared have been completely 
separable by flash column chromatography. The stereochemistry of the aldol 
94:694%PhCHO6
95:590%EtCHO5
98:295%(CH3)2CHCHO4
97:392%n-PrCHO3
97:394%(CH3)2CHCH2CHO2
96:479%PhCH=CHCHO1
dr (26:27)YieldAldehydeEntry
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adducts was determined by reductive cleavage of the adduct obtained in entry 4 
to afford (R)-4-methyl-pentane-1,3-diol, as confirmed by polarimetry.27 
 The observed stereochemistry in the acetate aldol reactions can be 
explained by two possible models (Figure 1.7). The enolization conditions in 
these acetate aldol additions are analogous to those employed in “non-Evans” 
syn-aldol additions for propionates. The propionate aldol additions are believed 
to proceed via a chelated transition state;6 therefore, diastereoselectivity would 
arise from the preference of the “R” group of the aldehyde to occupy the 
pseudoequatorial position to avoid a 1,3-diaxial interaction with both the auxiliary 
and one of the methyl groups on the mesityl group. Other possible transition 
states, such a nonchelated boat, cannot be ruled out. Further studies are 
necessary to distinguish which transition state is operational in these reactions. 
 
 
 
 
 
 
 
 
 
O
Ti
O
H
H
H
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N
S
S
Cl
Cl
Cl
Me
Me
Me
N
S
O
H
O
Cl4Ti R
H
S
Me
Me
Me
H
chelated chair non-chelated boat
S N
S O OH
R
Figure 1.7. Possible transition states to account for the observed stereochemistry.
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 Under the optimized reaction conditions, the acetate aldol addition using 
mesityl-substituted N-acetylthiazolidinethione 25 gives the “syn” acetate aldol 
adduct as the major diastereomer. We next investigated whether the “anti” 
acetate aldol adduct could be accessed from the same enantiomer of the 
auxiliary. In the case of the propionate aldol addition, one benefit of using a 
thiazolidinethione auxiliary is the ability to access both the “Evans” syn and “non-
Evans” syn aldol adducts by altering the stoichiometry of titanium tetrachloride 
and/or the amine base (Figure 1.2, vide supra). The presence of N-methyl 
pyrolidinone (NMP), or an excess of (−)-sparteine, has been shown to break 
chelation between titanium and the auxiliary, resulting in the formation of the 
“non-Evans” syn propionate aldol adduct.6  
 To investigate whether this selectivity reversal would be feasible for the 
acetate aldol addition, several experiments were run to see if the “anti” acetate 
aldol adduct could be obtained in the presence of NMP and (−)-sparteine (Table 
1.5). Despite optimization attempts, the “anti” acetate aldol adduct was only 
obtained in modest yield and diastereoselectivity. 
 
 
 
 
 
 
73:2756%1.01.01.03
74:2658%1.31.21.02
72:2854%-2.21.01
drYieldEq NMPEq (-)-sparteineEq TiCl4Entry
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C. Iterative Aldol Additions Using a Mesityl-Substituted Thiazolidinethione 
 To explore the utility of the acetate aldol addition in more stereochemically 
complex substrates, the application of the mesityl-substituted N-
acetylthiazolidinethione in double diastereoselective aldol additions30 using 
nonracemic aldehydes was investigated. Aldol adducts from both acetate aldol 
additions (30a) and propionate aldol additions (30b) underwent a t-
butyldimethylsilyl protection of the β-hydroxyl group, followed by reductive 
cleavage of the thiazolidinethione auxiliary, revealing enantiopure aldehydes 31a 
and 31b (Scheme 1.8). These nonracemic aldehydes were then subjected to 
acetate aldol additions with both enantiomers of the mesityl-substituted 
thiazolidinethione (21 and 25) to provide aldol adducts 32a, 32b, 33a and 33b in 
high yields and excellent diastereoselectivities. The presence of an α-substituent 
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on the aldehyde led to a drop in yield when the original enolization conditions 
were applied (1.1 equiv N-acetylthiazolidinethione, 1.1 equiv titanium 
tetrachloride, and 1.1 equiv diisopropylethylamine). The yield increased 
significantly when a slight excess of enolate was employed (1.5 equiv N-
acetylthiazolidinethione, 1.5 equiv titanium tetrachloride, and 1.5 equiv 
diisopropylethylamine). Because diastereoselectivity was high in all cases, this 
demonstrates that the selectivity of these acetate aldol additions is influenced by 
auxiliary control rather than substrate control. 
 
D. Summary 
 This chapter has described the concise synthesis of highly hindered 
oxazolidinethione and thiazolidinethione auxiliaries bearing mesityl directing 
groups that achieve high levels of diastereoselectivity for acetate aldol additions 
employing aliphatic, aromatic, and α, β-unsaturated aldehydes. In addition, these 
auxiliaries also provide excellent double diastereoselection in the acetate aldol 
addition of nonracemic aldehydes. This methodology finds wide application in the 
synthesis of a variety of polyketide-derived natural products, and has already 
been successfully applied to the total synthesis of (−)-pironetin.31 Efforts towards 
the application of this acetate aldol methodology to the total synthesis of (−)-
brevenal will be discussed in the following chapter. 
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 Chapter 2 
 
Progress Towards the Total Synthesis of (−)-Brevenal 
 
 
A. Background 
 
 (i) Isolation and Biological Activity of (−)-Brevenal 
 Marine polycyclic ether natural products have received much attention 
over the years due to their unique and highly complex molecular architecture, in 
addition to their diverse and potent biological activities.1-3 Cyclic polyethers, such 
as the ciguatoxins4 and maitotoxin5, are representative secondary metabolites 
produced by marine phytoplankton. A number of bioactive polyether natural 
products have been isolated from the marine dinoflagellate Karenia brevis, the 
organism responsible for toxic red tides along Florida’s Gulf Coast. The most 
well-known compounds isolated from K. brevis are a family of neurotoxins called 
the brevetoxins (Figure 2.1). The brevetoxins are responsible for massive kills of 
fish and marine animals such as dolphins and manatees. The red tides can also 
affect humans when the brevetoxins have become aerosolized in sea spray or 
bioaccumulated in shellfish. Inhaled brevetoxins cause respiratory irritation and 
breathing difficulties in sensitive populations.6 At high concentrations, ingested 
brevetoxins lead to a collection of symptoms commonly referred to as neurotoxic 
shellfish poisoning (NSP).7 
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 The brevetoxins bind with high affinity to site 5 of voltage sensitive sodium 
channels (VSSC) in neurons.8,9 Binding of brevetoxins to tissues containing 
VSSC results in membrane depolarization, repetitive firing, and increased sodium 
currents.10-12 Investigations using voltage clamp experiments indicate that 
brevetoxins activate VSSC by prolonging mean open time, inhibiting channel 
inactivation, thus extending the duration of sodium currents across the 
membrane.  
 Interestingly, the same organism which produces these potentially deadly 
toxins also produces a compound that displays antagonistic activity against the 
brevetoxins. This compound, brevenal, has been shown to competitively displace 
titrated dihydrobrevetoxin-B from VSSC in rat brain synaptosomes in a dose-
dependent manner, alleviating the toxic effects of brevetoxins in vivo.13,14 More 
importantly, picomolar concentrations of brevenal were found to increase 
tracheal mucus velocity to the same degree as that observed with millimolar 
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concentrations of a sodium channel blocker, amiloride, which is used in the 
treatment of the debilitating lung disorder cystic fibrosis.15 As such, brevenal 
represents a potential lead for the development of novel therapeutic agents for 
the treatment of mucociliary dysfunction associated with cystic fibrosis and other 
lung disorders. 
 (−)-Brevenal (34, Figure 2.2) was 
isolated in 2004 by Baden and coworkers. 
The structure of brevenal was disclosed 
based on 2D NMR studies; however, the 
absolute chemistry remained to be established. Brevenal is characterized by its 
pentacyclic polyether core arranged with four methyl and two hydroxyl groups, 
and its heavily substituted left-hand (E,E)-dienal side chain. The first total 
synthesis and absolute configuration was reported by Sasaki and coworkers in 
2006.16 To date, this is the only reported total synthesis of brevenal. 
 (ii) Previous Synthetic Efforts 
 Sasaki and coworkers first reported the total synthesis of brevenal (34) in 
2006, however, in 2008, they reported a revised, concise synthetic entry to the 
pentacyclic polyether core.17 Their retrosynthetic plan is depicted in Figure 2.3, in 
which the pentacyclic core 35 could be rapidly accessed from a Suzuki-Miyaura 
coupling18,19 of the AB-ring exo-olefin 36 and the DE-ring enol phosphate 37,  
followed by subsequent construction of the C-ring by a mixed 
thioacetalization/methylation sequence. The AB-ring exo-olefin 36 was 
retrosynthetically divided into alkylborate 38 and B-ring enol phosphate 39 based 
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on a further application of the Suzuki-Miyaura coupling/mixed thioacetalization 
strategy. Finally, the D-ring enol phosphate was traced back to the E-ring 40 via 
lactonization of the D-ring. This two-fold use of the Suzuki-Miyaura 
coupling/mixed thioacetalization strategy resulted in a highly convergent 
synthesis of brevenal. Employment of this strategy allowed Sasaki and 
coworkers to access (−)-brevenal with 46 steps in the longest linear sequence. 
 
 
  
 
 
 
 
 
 
 
 
 
   
  The synthesis of the AB-ring exo-olefin 36 began with iodination of alcohol 
41,20 followed by lithiation with t-butyllithium in the presence of B-MeO-9-BBN to 
generate the alkylborate, which was then coupled with enol phosphate 39 to 
afford enol ether 42 (Scheme 2.1). Selective hydroboration, followed by oxidation 
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of the resultant alcohol gave ketone 43. Removal of the MPM group and 
subsequent treatment with ethanethiol and zinc triflate provided the mixed 
thioacetal, which was displaced with the angular methyl group via a one-pot 
oxidation/methylation protocol,21 giving rise to bicycle 44. Removal of the benzyl 
groups and protection of the resultant primary alcohol as the TIPS ether gave 
alcohol 45, which was regioselectively eliminated by a one-pot procedure22 to 
yield olefin 46. After various protecting group manipulations, a dihydroxylation of 
the olefin furnished diol 47 as a single diastereomer. Protection of the diol and 
cleavage of the TIPS group gave the alcohol, which was iodinated and 
subsequently treated with potassium t-butoxide to afford the AB-ring exo-olefin 
36. 
 
 The synthesis of the DE-ring enol phosphate 37 commenced with the 
regioselective opening of the known epoxide 48,23 readily available from 1,5-
pentanediol in five steps (Scheme 2.2). The resultant diol 49 underwent selective 
sulfonylation of the primary alcohol, then epoxidation under basic conditions. 
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Epoxide 50 was then allylated with allylmagnesium bromide, and the free 
hydroxyl group was protected as the benzyl ether. A Wacker oxidation delivered 
methyl ketone 51,24 and deprotection of the MPM group followed by attachment 
of an acrylate unit led to the β-alkoxyacrylate. Treatment with samarium (II) 
iodide furnished the lactone 52 as a single diastereomer, which underwent 
reduction followed by Wittig methylenation to afford alcohol 53. In four steps, 53 
was converted to diol 54, which was converted to the lactone via a direct 
oxidative cyclization.25 Enolization then generated the DE-ring enol phosphate 37. 
  
 Assembly of the AB-ring exo-olefin 36 and the DE-ring enol phosphate 37 
and subsequent construction of the C-ring was accomplished according to 
Sasaki’s Suzuki-Miyaura coupling-based strategy (Scheme 2.3).19 
Stereoselective hydroboration of 36 using 9-BBN-H generated an alkylborane, 
which was reacted with 37 in the presence of cesium carbonate and Pd(PPh3)4 to 
furnish enol ether 55 as a single stereoisomer. Hydroboration of the enol ether 
proceeded stereoselectively to give the alcohol, which underwent oxidation to 
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give ketone 56 as a single stereoisomer. Cleavage of the PMB and silyl groups, 
mixed thioacetalization, and ensuing silylation of the resultant unprotected 
hydroxyl group delivered mixed thioacetal 57. The thioethyl group was then 
oxidized and displaced with a methyl nucleophile in a one-pot manner,21 giving 
rise to the pentacyclic polyether, which then underwent debenzylation26 to give 
alcohol 58. 
 
 Having constructed the pentacyclic polyether core, efforts were then 
focused on the construction of the left-hand side chain (Scheme 2.4). Dess-
Martin oxidation27 of alcohol 58 to the aldehyde followed by treatment with Ohira-
Bestmann reagent28,29 produced a terminal alkyne, which was then methylated to 
provide alkyne 59. The robust TBS groups were replaced with easily removable 
TES ethers. Regioselective silylcupration delivered the desired vinylsilane 60 in 
approximately 9:1 regioselectivity. Conversion of 60 to the vinyl iodide30, followed 
by a Stille coupling31 with vinyl stannane 61 proceeded smoothly to furnish (E, 
E)-diene 62 as a single stereoisomer. After protection of the allylic alcohol as the 
TBDPS ether, the primary TES ether was selectively removed to give alcohol 63. 
Introduction of the right-hand (Z)-diene side chain was performed via Nicolaou’s 
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procedure.32 Thus, 63 was oxidized and then subjected to a Wittig olefination 
using ylide 64. Subsequent treatment with hydrogen peroxide led to conjugated 
(Z)-diene 65. Global deprotection of the silyl groups followed by selective 
oxidation of the allylic alcohol completed the synthesis of (−)-brevenal (34). 
 
 
B. Studies Towards the Total Synthesis of (−)-Brevenal 
 (i) Retrosynthetic Analysis 
  Our original retrosynthetic analysis (Figure 2.4) envisioned a highly 
convergent approach to brevenal, wherein the left- and right-hand unsaturated 
side chains are installed late-stage. The pentacyclic polyether core was 
envisaged to arise from a Horner-Wadsworth-Emmons coupling of the AB-ring β-
ketophosphonate 68 and the E-ring aldehyde 69 to give enone 67, followed by an 
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acid-catalyzed cyclodehydration to close the D-ring, generating tetracycle 66. 
Closure of the C-ring would then provide the brevenal pentacyclic core.  
 
 
 
 
 
 
 
  
 
 (ii)  Application of the Acetate Aldol Methodology to the Synthesis of the AB- 
  Ring Fragment. 
 
  Initial efforts towards the total synthesis of (−)-brevenal focused on the 
construction of the AB-ring β-ketophosphonate 68, in which our newly developed 
acetate aldol methodology, discussed in the previous chapter, would serve as a 
key step. The first proposed retrosynthetic plan for the synthesis of 68 is outlined 
in Figure 2.5. β-Ketophosphonate 68 was expected to arise from methyl ester 70. 
Figure 2.5. Original retrosynthetic analysis of AB-ring fragment 68.
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The B-ring would be formed via an intramolecular Michael addition of alcohol 71, 
which in turn will stem from enol ether 72. The enol ether would arise from a one-
pot enone reduction, TMS deprotection, and cyclodehydration of enone 73, which 
would be generated from a Horner-Wadsworth-Emmons coupling of β-
ketophosphonate 74 and aldehyde 75. β-ketophosphonate 74 and aldehyde 75 
would be accessed from an acetate aldol adduct, and a propionate aldol adduct, 
respectively. 
  The synthesis of aldehyde 75 began with a highly diastereoselective 
“Evans” syn propionate aldol addition33 between phenylalanine-derived N-
propionylthiazolidinethione 76 and aldehyde 77 (Scheme 2.5). The resultant aldol 
adduct 78 was protected as the TMS ether, and the auxiliary underwent reductive 
cleavage to furnish the desired aldehyde 75. 
 
  Efforts were then focused on the synthesis of β-ketophosphonate 74 
(Scheme 2.6). The key step to 74 involved an acetate aldol addition using 
mesityl-substituted N-acetylthiazolidinethione 21,34 discussed in the previous 
chapter. Thus, N-acetylthiazolidinethione 21 underwent an acetate aldol addition 
with aldehyde 79, synthesized in four steps from commercially available (R)-
benzylglycidyl ether (81). The addition proceeded in high yield, however, very 
poor diastereoselectivity was observed. It was expected that this aldol addition 
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would be a “matched” case, in that the acetate aldol addition results in “syn” 
acetate aldol adducts, and the presence of an α-silyl ether on the aldehyde would 
lead to the Felkin-Anh35,36 product, giving rise to the stereochemistry observed in 
aldol adduct 80. Poor diastereoselectivity, however, suggested that perhaps this 
aldol addition was a “mismatched” case.  
  
  To test this hypothesis, the opposite enantiomer of the auxiliary, N-
acetylthiazolidinethione 25, underwent an acetate aldol addition with aldehyde 79, 
furnishing adduct 84 in excellent yield and diastereoselectivity (Scheme 2.7). The 
high diastereoselectivity suggested that this reaction is perhaps proceeding 
through chelation control, 
resulting in the anti-Felkin 
product. To prevent chelation, the 
TBS group on aldehyde 79 was 
replaced with a TIPS group, as bulky silyl groups are generally understood to be 
poor coordinators. This, however, still resulted in poor diastereoselectivity, most 
likely due to the presence of titanium tetrachloride causing the reaction to 
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proceed through chelation control. 
  At this point, the synthetic route to the AB-ring β-ketophosphonate was 
modified by performing the acetate aldol addition with cinnamaldehyde instead of 
aldehyde 79 (Scheme 2.8). This would not alter the retrosynthetic strategy 
outlined in Figure 2.3 as the styrene moiety could be cleaved via ozonolysis then 
subjected to a vinyl addition, TBS deprotection, and acetonide protection to 
access the necessary right-hand side chain of protected diol 71 (Figure 2.5, vide 
supra). The acetate aldol addition was carried out with N-acetylthiazolidinethione 
21 and cinnamaldehyde, providing “syn” acetate aldol adduct 85 with excellent 
diastereoselectivity. Upon treatment with TBSOTf and 2,6-lutidine, the free 
hydroxyl group was protected as the TBS ether, and the auxiliary was the 
displaced with lithiodimethyl methylphosphonate to afford β-ketophosphonate 
86.37,38 A Horner-Wadsworth-Emmons coupling of 86 and aldehyde 75, 
synthesized in Scheme 2.5,  in the presence of barium hydroxide gave enone 
87.39 A one-pot enone reduction, TMS deprotection, and cyclodehydration, using 
Wilkinson’s catalyst followed by the addition of pyridinium p-toluenesulfonate 
(PPTS),40,41 was then attempted to access the A-ring enol ether 88, however, this 
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reaction proved to be unsuccessful.  
  To circumvent this problem, the enone reduction, TMS deprotection, and 
cyclodehydration reactions were carried out stepwise. The enone reduction 
proved to be difficult in that a variety of reaction conditions were employed 
resulting in either decomposition or no reaction (Table 2.1). Eventually, it was 
found that diisobutylaluminum hydride and hexamethylphosphoramide, in the 
presence of a catalytic amount of methyl copper,42 furnished ketone 89 in high 
yield (entry 6). 
 
 
 
 
 
  
  
 Ketone 89 was then treated with PPTS and heat to induce removal of the 
TMS ether followed by subsequent cyclodehydration to produce the A-ring enol 
ether 88 (Scheme 2.9). This reaction, however, only led to decomposition of the 
starting material; therefore, the TMS group was removed in the presence of 
ammonium fluoride43 and methanol to reveal hydroxy ketone 90. Treatment of 90 
with PPTS was expected to give rise to enol ether 88; however, conjugated triene 
91 was obtained instead. It is believed that under acidic conditions, the TBS 
ether acts as a leaving group, whereby the cation being generated is stabilized 
TIPSO
OTMS
Me
O OTBS
Ph
TIPSO
OTMS
Me
O OTBS
Ph
Table 2.1. Attempts at enone reduction.
87 89
94%THF, -50 oCi-Bu2AlH, HMPA, MeCu (cat.)6
no reactionTHF, 0 oCi-Bu2AlH, HMPA5
decompositionMeOH, Et2O, 0 oCLiBH44
no reactionMeOH, H2O, 23 oCNiCl2 · 6H2O, NaBH43
decompositiontoluene, 23 oC[Ph3PCuH]62
decompositiontoluene, 50 oC(Ph3P)3RhCl, Me2PhSiH1
YieldConditionsReagentsEntry
 35 
by the styrene component. 
 
 
 
 
 
 
 
 
 
 To prevent the formation of the undesired triene, it was necessary to 
remove the styrene component from the substrate. To do this, the acetate aldol 
addition was revisited using crotonaldehyde instead of cinnamaldehyde, 
generating adduct 92 in good yield and excellent diastereoselectivity (Scheme 
2.10). In the same manner depicted in Scheme 2.8, aldol adduct 92 was 
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Scheme 2.10. Revised synthesis of A-ring enol ether.
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converted to hydroxy ketone 95 in five steps. Upon treatment with PPTS to 
generate the desired enol ether 96, the undesired conjugated triene 97 was once 
again obtained as the major product. This time, it was thought that having a 
terminal olefin instead of an internal olefin would prevent elimination of the TBS 
ether.  
 To do this, the acetate aldol addition was revisited once again using 
acrolein instead of crotonaldehyde (Scheme 2.11). Aldol adduct 98 was furnished 
in high yield and excellent diastereoselectivity. As before, the free hydroxyl group 
was protected as the TBS ether and the thiazolidinethione was displaced to 
afford β-ketophosphonate 99. The ensuing Horner-Wadsworth-Emmons coupling 
of 99 and aldehyde 75 generated enone 100 in high yield, which was then 
subjected to a 1,4-reduction followed by TMS deprotection with ammonium 
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fluoride to provide hydroxy ketone 101. At this point, the necessary 
cyclodehydration reaction was attempted. In the presence of PPTS, the desired 
enol ether 102 was obtained in a 1:1 mixture with conjugated triene 103. Upon 
examination of various cyclodehydration conditions, it was found that enol ether 
102 could be obtained in excellent yield in the presence of phosphorus pentoxide, 
a reagent commonly used to effect various cyclizations.44,45 Under these 
conditions, no formation of triene 103 was observed. 
 With the desired A-ring enol ether in hand, efforts then focused on an 
epoxidation-methylation sequence to access A-ring pyran 104 using 
methodology developed by Rainier (Scheme 2.12).46,47 It was hoped that 
treatment of enol ether 102 with dimethyl dioxirane48 (DMDO) would 
chemoselectively form the epoxide on the olefin of the enol ether from the less 
hindered face of the six-membered ring. In the same pot, the solvent would then 
be removed under an argon purge and a large excess of trimethyl aluminum 
would be added to coordinate to the epoxide and selectively deliver a methyl 
group to the bottom face of the pyran to generate alcohol 104. Treatment with 
DMDO did indeed lead to the selective formation of the desired epoxide without 
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any side reactions with the terminal olefin. Addition of trimethylaluminum, 
however, did not yield the desired alcohol; rather, 2D NMR studies and mass 
spectrometry revealed the formation of triol 105. To confirm that alcohol 104 was 
not being formed, the product obtained from the epoxidation-methylation reaction 
was subjected to an acetate protection. The NMR of the product obtained 
showed the presence of two acetate groups, suggesting that more than one free 
hydroxyl group was present in the starting material. While triol 105 has three free 
hydroxyl groups instead of two, one of the hydroxy groups is tertiary, and thereby 
more difficult to protect. 
 A possible mechanism for the formation of triol 105 is depicted in Figure 
2.6. It is believed that after treatment with DMDO, the epoxide was being opened 
by the action of adventitious water rather than that of trimethyl aluminum, leading 
to the formation of acetal 107. Addition of a large excess of trimethyl aluminum 
would then generate oxocarbenium cation 108. Addition of a methyl nucleophile 
into the resultant oxocarbenium cation would then furnish triol 105. 
 
 At this point, a variety of alterations were made to the reaction conditions 
to avoid the presence of water and it was found that “acetone-free” DMDO40 
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successfully avoided formation of the undesired triol 105. The desired product, 
however, was only obtained in modest yield (58%) and no diastereoselectivity 
was observed. One possible explanation for the lack of diastereoselectivity could 
be attributed to coordination of trimethyl aluminum to the TBS ether, causing the 
methyl group to be delivered to either face of the oxocarbenium. To avoid this 
problem, we next investigated an acid-catalyzed opening of the epoxide to form 
mixed acetal 109 (Scheme 2.13). If successful, the methoxy group could later be 
displaced for a methyl group. Enol ether 102 was first treated with DMDO to form 
the epoxide. The solvent was then removed under an argon purge and methanol, 
followed by a catalytic amount of PPTS, was added. These reaction conditions, 
however, resulted in no reaction. The reaction was then attempted with a 
stronger acid, camphorsulfonic acid (CSA), to promote the epoxide opening, but 
this resulted only in deprotection of the TBS protecting group. The TBS group 
was then replaced with the bulkier TIPS protecting group to give enol ether 110, 
which was treated with DMDO followed by CSA and methanol. This reaction 
resulted in a mixture of unidentifiable products. 
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 Due to the difficulties encountered with this epoxidation-methylation 
strategy, we concluded that a substrate more similar to that of Rainier46 would be 
necessary to overcome this step in the synthesis (Figure 2.7). To do so would 
involve moving the protected hydroxyl group of the right-hand side chain farther 
away from the reaction site by revising the synthetic strategy of the AB-ring 
fragment to no longer include the acetate aldol addition. The new target enol 
ether for the epoxidation-methylation sequence is shown in Figure 2.8. 
 
 
 
 
 
 
 
 
 (iii) Revised Synthesis of the AB-Ring Fragment 
 The revised retrosynthesis of the AB-ring β-ketophosphonate 68 is 
illustrated in Figure 2.9, in which the key step is no longer an acetate aldol 
addition. Rather, the revised retrosynthesis relies on the glycolate alkylation/ring-
closing metathesis strategy, developed in the Crimmins laboratory, to access 
medium-ring ethers.49,50  The AB-ring fragment 68 is expected to arise from nitrile 
113. The seven-membered B-ring will be formed via a ring-closing metathesis 
reaction of diene 114, which will stem from an alkylation of glycolate 115 followed 
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by conversion of the oxazolidinone to the olefin. Enol ether 112 will arise from the 
1,4-reduction and TMS deprotection of enone 116, which will be generated from 
the Horner-Wadsworth-Emmons coupling of aldehyde 75 and β-ketophosphonate 
117. 
 
 The revised synthesis of the AB-ring fragment 68 began with synthesis of 
enol ether 112, to test its performance in Rainier’s epoxidation-methylation 
reaction (Scheme 2.14). Commercially available 1,4-butanediol underwent 
monobenzylation51 followed by a Jones’ oxidation52 to afford carboxylic acid 118. 
Conversion to the methyl ester under acidic conditions followed by displacement 
of the auxiliary with lithiodimethyl methylphosphonate then furnished β-
ketophosphonate 117. β-ketophosphonate 117 and aldehyde 75 were coupling 
via a Horner-Wadsworth-Emmons reaction to give enone 116, which then 
underwent a 1,4-reduction followed by TMS deprotection to provide hydroxy 
ketone 119. It should be noted that the acidic workup of the enone reduction 
resulted in partial loss of the TMS group; therefore, the crude mixture of products 
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was treated with ammonium fluoride, resulting in complete removal of the TMS 
group, and the yield was calculated over two steps. The resultant hydroxy ketone 
119 was exposed to phosphorus pentoxide to induce cyclodehydration to form 
the A-ring enol ether 112; however, these reaction conditions provided 
inconsistent results, sometimes providing 112 in high yield and other times 
resulting in no reaction. Cyclodehydration using PPTS in the presence of 
molecular sieves was examined and gave the desired enol ether 112 in moderate 
yield (42-60%) in addition to unreacted starting material. In the presence of a 
stronger acid, such as CSA, enol ether 112 was obtained in excellent yield. 
 
 With the necessary enol ether 112 in hand, efforts then focused on the 
epoxidation-methylation reaction to afford alcohol 120 (Scheme 2.15). Upon 
addition of DMDO, enol ether 112 underwent facile conversion to the 
corresponding epoxide. After the solvent switch, exposure to trimethylaluminum 
provided alcohol 120 in poor yield and low diastereoselectivity. An acid-catalyzed 
opening of the epoxide in the presence of methanol was then attempted. Mixed 
acetal 121 was obtained as a single diastereomer. 
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 With the successful formation of mixed methyl acetal 121, we then 
decided to make the right-hand side chain one carbon shorter so as to ease the 
manipulation of the side chain later in the synthesis (Scheme 2.16). To do this, a 
synthesis identical to that depicted in Scheme 2.14 was employed, with the 
exception that 1,3-propanediol was used in place of 1,4-butanediol. From 1,3-
propanediol, enol ether 127 was obtained in eight steps. Upon exposure to the 
epoxidation-acetalization reaction conditions, mixed methyl acetal 128 was 
obtained in good yield, as a single diastereomer. 
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Scheme 2.16. Synthesis of mixed acetal 128.
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 At this point, it was necessary to displace the methoxy group of mixed 
acetal 128 and install the angular methyl, generating pyran 129 (Scheme 2.17). 
Exposure of 128 to trimethyl aluminum in the presence of boron trifluoride 
etherate was expected to furnish pyran 129; however, these conditions resulted 
only in the recovery of starting material. It was thought that protecting the free 
hydroxyl group might be necessary for the success of the reaction. Therefore, the 
free hydroxyl group was protected as the TES ether. The methylation reaction 
was then attempted, once again resulting in no reaction. We then turned to 
Nicolaou’s strategy for accessing medium-ring systems via cyclizations of 
hydroxy dithioketals.21 Thus, enol ether 127 was converted to the epoxide, which 
was opened in the presence of zinc triflate and ethanethiol furnishing mixed 
thioacetal 130. Initially, replacement of the thioethyl group for the methyl group 
was attempted via the one-pot procedure utilized by Sasaki in the presence of 
the free hydroxyl group,21 generating pyran 129 in modest yield. In an effort to 
increase the yield, the free hydroxyl group was protected as the TES ether. 
Exposure to m-CPBA followed by trimethyl aluminum gave the desired pyran 131 
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Scheme 2.17. Synthesis of the A-ring pyran 131.
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in high yield as a single diastereomer. 
 With the necessary methyl group in place, the synthesis of the AB-ring 
fragment 68 continued (Scheme 2.18). Pyran 131 was subjected to 
hydrogenation conditions to reductively cleave the benzyl ether. These conditions, 
however, led to partial removal of the TES protecting group in addition to the 
benzyl group. Benzyl cleavage was thus realized in the presence of sodium 
naphthalenide53 to give the desired alcohol, which was oxidized under Swern 
conditions54 to furnish aldehyde 132. A Wittig methylenation55 followed by 
cleavage of the TES ether56 then ensued, affording alcohol 133. It was found that 
PPTS was not a strong enough acid for the TES cleavage and that CSA was a 
better choice. CSA in the presence of methanol led to partial cleavage of the 
TIPS protecting group as well. Using a larger nucleophile such as ethanol 
alleviated this problem, providing alcohol 133 in high yield, with only a negligible 
amount of TIPS deprotection observed. 
 
 With alcohol 133 in hand, our glycolate alkylation/ring-closing metathesis 
strategy49 was applied to construct the seven-membered B-ring (Scheme 2.19). 
Alcohol 133 was transformed to the glycolic acid in the presence of sodium 
hydride and bromoacetic acid. In one pot, the resultant acid was converted to the 
mixed pivalic anhydride and treated in situ with the lithium salt of (R)-4-benzyl-2-
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oxazolidinone to produce acyl oxazolidinone 115. Treatment of the sodium 
enolate of 115 with bromoacetonitrile resulted in a highly diastereoselective 
glycolate alkylation57 to furnish the nitrile. The highest yield obtained, however, 
was only 52% due to the presence of an unidentifiable byproduct which was 
formed during the enolization process. All attempts to optimize this reaction, 
including lowering the reaction temperature and screening various bases for 
enolization, were unsuccessful. The oxazolidinone was then cleaved to afford 
alcohol 134, which was oxidized to the aldehyde under Swern conditions. It 
should be noted that oxidation of 134 with Dess-Martin periodinane gave much 
lower yields due to decomposition. At this point, a methylene Wittig reaction was 
performed to generate diene 114, however, the presence of the nitrile facilitated 
elimination, thus reforming alcohol 133. Attempts at methylenation with the 
Tebbe reagent58 led to decomposition. To prevent elimination, the methylene 
Wittig reaction was performed using crystallized, salt-free 
methylenetriphenylphosphorane,59,60 thereby giving rise to the desired diene 114. 
Upon exposure to Grubbs’ 2nd generation catalyst,61 the seven-membered B-ring 
was formed providing bicycle 135. 
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  With the AB-ring core formed, completion of the fragment commenced 
(Scheme 2.20). Olefin 135 underwent dihydroxylation to furnish the diol as a 
single diastereomer, which was then protected in the presence of PPTS and 2-
methyoxypropene to afford acetonide 113. The nitrile was then converted to the 
β-ketophosphonate by reduction to the aldehyde, followed by addition of 
lithiodimethyl methylphosphonate to give the β-hydroxyphosphonate, and then 
oxidation with Dess-Martin periodinane to furnish AB-ring β-ketophosphonate 
fragment 68 with 27 steps in the longest linear sequence. 
 
 (iv) Coupling of the AB-Ring and E-Ring Fragments 
  With the AB-ring β-ketophosphonate 68 in hand, we were then ready to 
proceed with the coupling of 68 with the E-ring aldehyde 69. Aldehyde 69 has 
been synthesized by Dr. Anita Mattson for the synthesis of hemibrevetoxin B 
(Scheme 2.21). Taking advantage of the Kobayashi lactate aldol addition,62 
superquat 136 was used to prepare aldol adduct 137. The auxiliary was 
converted to the methyl ester and the free hydroxyl group was protected as the 
TES ether to give ester 138, which was converted to aldehyde 139 in two steps. 
After methylenation, the TES group was removed using t-butylammonium 
fluoride to furnish alcohol 140, which was converted to glycolyl oxazolidinone 141 
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via the glycolic acid. Alkylation with bromoacetonitrile followed by cleavage of the 
auxiliary then furnished alcohol 142. Oxidation to the aldehyde under Swern 
conditions, followed by vinyl addition gave allylic alcohols 144 and 145 as a 5:1 
mixture of diastereomers, which were both subjected to Grubbs’ 2nd generation 
catalyst to provide the E-ring alcohols 146 and 147. The undesired diastereomer 
146 could be converted to 147 via a two step oxidation/reduction sequence. The 
free alcohol was protected as the TES ether and the nitrile was then reduced with 
diisobutylaluminum hydride to generate the E-ring aldehyde 69 in 16 steps. 
  
 With both the AB-ring β-ketophosphonate and the E-ring aldehyde 
available, a Horner-Wadsworth-Emmons coupling between the fragments 
ensued, furnishing enone 67 in excellent yield (Scheme 2.22). 
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 (v) Attempts at D-Ring Formation 
  With fragments 68 and 69 successfully coupled, efforts then focused on 
the formation of the seven-membered D-ring enol ether. The original plan to 
synthesize the D-ring was to utilize the one-pot enone reduction, TES 
deprotection, and cyclodehydration strategy (Scheme 2.23). While this strategy 
has been successful for the formation of six-membered cyclic enol ethers,40 there 
are no examples in the literature in which a seven-membered cyclic enol ether is 
formed via this protocol. Treatment of enone 67 with Wilkinson’s catalyst and 
dimethylphenylsilane cleanly gave the silyl enol ether, however, addition of PPTS 
slowly led to formation of TES deprotected ketone 149, with no trace of desired 
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enol ether 66, despite much care taken to avoid the presence of water in the 
reaction. Stronger acids, such as CSA and p-TsOH were also used; however, 
only TES deprotected ketone 149 was obtained. 
  Our next strategy was to replace the TES protecting with the more labile 
TMS protecting group to facilitate the deprotection step to generate the 
necessary free hydroxyl group for the pending cyclodehydration. Thus β-
ketophosphonate 68 was coupled with the TMS protected E-ring aldehyde to give 
enone 150. Once again, only TMS deprotected ketone 149 was obtained 
(Scheme 2.24). Removal of the TMS group prior to the enol ether formation step 
was also attempted. Treatment of enone 150 with HF·pyridine gave the desired 
alcohol 151. The alcohol had to be taken on without purification as exposure to 
deactivated silica gel led to a Michael addition of the free hydroxyl group into the 
enone. Subjection to the one-pot enone reduction and cyclodehydration protocol 
led to decomposition, most likely due to the instability of 151. 
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 At this point, the one-pot enone reduction and cyclodehydration strategy 
was abandoned. Enone 67 was subjected to a hydrogenation to reduce both 
olefins and cleave the two benzyl ethers, generating diol 152 (Table 2.2). Various 
solvents, acids, and temperatures were screened to effect the cyclodehydration 
of 152, however, only the formation of TES deprotected ketone 149 or 
decomposition occurred. 
 
 Lewis acids were also screened in an attempt to form the D-ring enol ether 
(Scheme 2.25). TMS triflate, in the presence of trimethylsilane, has been shown 
to induce a reductive cyclization to access the seven-membered C-ring of 
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Fujiwara’s synthesis of hemibrevetoxin B.63 A variation of this protocol was 
attempted, resulting in decomposition, most likely due to loss of the acetonide. 
Cyclizations with additional Lewis acids, such as bismuth tribromide64 and 
scandium triflate, were also carried out, also resulting in decomposition. 
 We next investigated accessing the D-ring enol ether via cyclization of 
dimethyl ketal 156 or dithioketal 157 (Scheme 2.26). Formation of the dimethyl 
ketal was first attempted in the presence of PPTS, methanol, and trimethyl 
orthoformate, resulting only in the decomposition of the starting material. 
Ketalization was also attempted using Noyori’s protocol,65 also resulting in 
decomposition. It is believed that these conditions were not amenable to the 
presence of the acetonide on ketone 154. Dithioketalization21 of 154 was 
successful, albeit low yielding; however, attempts at cyclization to access mixed 
thioacetal 158 were met with failure. 
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 Due to the incompatibility of many of the cyclodehydration conditions with 
the acetonide protecting group, our next strategy was to replace the acetonide 
with two benzyl groups (Scheme 2.27). To do this, diol 159 was treated with 
sodium hydride and benzyl bromide, generating the dibenzyl protected diol 160 in 
modest yield, in addition to the monoprotected product. Diol 160 then underwent 
reduction of the nitrile and the resultant aldehyde was converted to β-
hydroxyphosphonate 161. The modest yield of this reaction can be attributed to 
the steric bulk associated with the benzyl group closest to the reaction site. 
Finally, oxidation with Dess-Martin periodinane furnished AB-ring β-
ketophosphonate 162. A Horner-Wadsworth-Emmons coupling with E-ring 
aldehyde 163 gave enone 164 which was then subjected to a 1,4-reduction using 
Wilkinson’s catalyst and PPTS to give TMS deprotected hydroxy ketone 165. 
Treatment with Fujiwara’s conditions to induce a cyclodehydration to form the D-
ring enol ether 166 only led to decomposition of the starting material. 
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 It was thought that the Bn-protected allylic alcohol in the E ring was 
causing stability issues of ketone 165 in the presence of a Lewis acid, therefore, 
the olefin was reduced using Crabtree’s catalyst66 to give ketone 167 (Scheme 
2.28). Cyclodehydration under Fujiwara’s conditions once again resulted in 
decomposition. Treatment of 167 with PPTS or CSA to induce cyclodehydration 
only led to recovery of starting material. 
 
  
 (vi) Revised Retrosynthesis of (−)-Brevenal 
 Due to the failures associated with formation of the D-ring enol ether, the 
retrosynthetic plan for (−)-brevenal was then revised (Figure 2.10). The revised 
plan involves coupling of AB-ring aldehyde 173 with E-ring β-ketophosphonate 
172 to give enone 171. Following a 1,4-reduction, the acetonide will then be 
removed and an acid-catalyzed cyclodehydration will ensue to form the six-
membered C-ring enol ether 170. Manipulation of the enol ether to give ketone 
169 followed by formation of the D-ring via acetalization will the give the 
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pentacyclic polyether core. Installation of the left- and right-hand side chains will 
then furnish (−)-brevenal (34). This sequence is analogous to that used in the 
Crimmins synthesis of the BCDE fragment of brevetoxin A.40 This work will be 
reported in due course. 
 
 
C. Summary 
 The asymmetric propionate aldol addition using the chlorotitanium 
enolates of acylthiazolidinethiones has been successfully applied in our efforts 
towards the total synthesis of (−)-brevenal. The glycolate alkylation/ring-closing 
metathesis strategy has also been effective in the synthesis of both the AB-ring 
and E-ring fragments. The AB-ring β-ketophosphonate has been synthesized in 
27 steps in the longest linear sequence, and the E-ring aldehyde has been 
prepared in 16 linear steps. If the synthesis proceeds as planned in the revised 
route (Figure 2.10), (−)-brevenal will be constructed with a longest linear 
sequence of 34 steps. 
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Chapter 3 
Experimental Information and NMR spectra for Chapter 1 
 
 Methods and Materials: Infrared (IR) spectra were obtained using a 
Jasco 460 Plus Fourier transform infrared spectrometer and values reported in 
cm-1. Proton and carbon nuclear magnetic resonance (1H and 13C NMR) spectra 
were recorded on the Bruker 400 (1H at 400 MHz; 13C at 100 MHz). Optical 
rotations were determined using a Jasco P1010 polarimeter. Thin layer 
chromatography (TLC) was conducted on silica gel F254 TLC plates purchased 
from Scientific Adsorbents, Inc. Flash column chromatography was carried out 
using silica gel (32 to 63 µm) purchased from Scientific Adsorbents, Inc. Diethyl 
ether (Et2O), tetrahydrofuran (THF), dichloromethane (CH2Cl2), and toluene were 
dried by being passed through a column of neutral alumina under nitrogen 
immediately prior to use. Alkylamines were distilled from calcium hydride 
immediately prior to use. Mesitylmagnesium bromide was synthesized using 
standard Grignard techniques from 2-bromomesitylene. (R)-(+)-2-methyl-2-
propanesulfinamide and (S)-(-)-2-methyl-2-propanesulfinamide were prepared 
using Ellman’s procedure. 1  All other reagents and solvents were used as 
received from the manufacturer. All air and water sensitive reactions were 
                                                 
1
 Weix, D. J.; Ellman, J. A. Org. Synth., 2005, 82, 57. 
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performed in flasks flame dried under positive flow argon and conducted under 
an argon atmosphere. 
 
S N
O H
OPMB
 
Imine 11: To a dry 25 mL round-bottom flask, under argon, was added (R)-
(+)-2-methyl-2-propanesulfinamide (0.715 g, 5.90 mmol) and 12 mL of CH2Cl2. 
Anhydrous CuSO4 (2.07 g, 13.0 mmol) was added in one portion followed by (4-
methoxy-benzyloxy)-acetaldehyde (1.17 g, 6.49 mmol). The reaction mixture was 
stirred at room temperature for 24 h, filtered through a pad of celite, and 
concentrated under reduced pressure. The crude product was purified by flash 
column chromatography (25% EtOAc/Hex to 35% EtOAc/Hex) to provide the 
product as a pale yellow oil (1.67 g, 85%). 1H NMR (400 MHz, CDCl3): δ 1.17 (s, 
9H), 3.76 (s, 3H), 4.33 (s, 2H), 4.52 (s, 2H), 6.85 (d, 2H, J = 8.4 Hz), 7.24 (d, 2H, 
J = 8.4), 8.07 (s, 1H). 13C NMR (100 MHz, CDCl3): δ 22.3, 55.1, 56.8, 70.8, 72.8, 
113.8, 129.1, 129.4, 159.4, 166.7. IR (film): 2959, 2866, 1633, 1613, 1514, 1363, 
1249, 1175 cm-1. ESI-MS: C14H21NO3S [M+H] calc. 284.4, found 284.2. [α]26D = -
173° (c = 1.25, CH 2Cl2). 
 
S N
H
O Mes
OPMB
 
 Protected amino alcohol 12: To a dry 250 mL round-bottom flask, under 
argon, was added imine 11 (4.00 g, 14.1 mmol) and 71 mL of toluene and the 
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flask was cooled to −78 °C. To this solution was sl owly added mesityl 
magnesium bromide (5.0 equiv), prepared from 4.30 g Mg turnings (0.18 mol), 
24.0 mL 2-bromomesitylene (0.17 mol) and 80 mL of dry ether. The mixture was 
stirred for 2 h at −78 °C upon which the reaction w as quenched with saturated 
ammonium chloride. The layers were separated and the aqueous layer was 
extracted with ethyl acetate (2x). The combined organic layers were dried over 
Na2SO4, filtered, and concentrated under reduced pressure. The crude product 
was purified by flash column chromatography (40% EtOAc/Hex to 70% 
EtOAc/Hex) to provide a single diastereomer of the product as a yellow oil (5.40 
g, 95%). 1H NMR (400 MHz, CDCl3): δ 1.19 (s, 9H), 2.23 (s, 3H), 2.39 (s, 6H), 
3.51 (dd, 1H, J = 4.0, 10.0 Hz), 3.78 (s, 3H), 3.95 (t, 1H, J = 10.4 Hz), 4.11 (s, 
1H), 4.51 (ABq, 2H, JAB= 11.6 Hz, ∆ν AB =  75.9 Hz), 5.12 (ddd, 1H, J = 10.4, 3.6, 
1.2 Hz), 6.80 (s, 2H), 6.87 (d, 2H, J = 8.4 Hz), 7.26 (d, 2H, J = 8.8 Hz). 13C NMR 
(100 MHz, CDCl3): δ 20.7, 20.9, 22.5, 52.7, 54.8, 55.1, 69.8, 72.0, 113.7, 129.3, 
129.4, 129.7, 140.0, 137.2, 137.8, 159.2. IR (film): 3277, 2955, 2866, 1612, 
1513, 1464, 1363, 1249, 1174 cm-1. ESI-MS: C23H33NO3S [M+H] calc. 404.6, 
found 404.2. [α]25D = -86.1° (c = 1.65, CH 2Cl2). 
 
H2N
OH
 
  Amino alcohol 13: To a dry 250 mL round-bottom flask, under argon, 
was added protected amino alcohol 12 (4.50 g, 11.2 mmol) in 23 mL of MeOH. 
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To this solution was added 4 N HCl/dioxane (28.0 mL, 112.0 mmol) and the 
solution was stirred for 1 h at room temperature. The solution was then 
concentrated under reduced pressure. The residue was dissolved in ether and 4 
N NaOH (200 mL) was slowly added while stirring. The layers were separated 
and the aqueous layer was extracted with ether (2x). The combined organic 
layers were dried over Na2SO4 and concentrated under reduced pressure. The 
crude product was purified by flash column chromatography (80% EtOAc/Hex to 
10% MeOH/CH2Cl2) to provide the amino alcohol as a pale yellow solid (1.52 g, 
76%).1H NMR (400 MHz, CDCl3): δ 2.25 (s, 3H), 2.40 (s, 6H), 2.60 (brs, 3H), 
3.62 (dd, 1H, J = 4.0, 10.8 Hz), 3.83 (t, 1H, J = 12.0 Hz), 4.47 (dd, 1H, J = 4.8, 
10.0 Hz). 6.83 (s, 2H). 13C NMR (100 MHz, CDCl3): δ 20.6, 21.2, 53.9, 64.6, 
130.3, 134.8, 136.2, 136.6. IR (film): 3364, 3300, 2954, 2920, 2867, 1610, 1455, 
1378, 1249 cm-1.  ESI-MS: C11H17NO [M+H] calc. 180.3, found 180.2. [α]25D = -
25.9° (c = 0.40, CH 2Cl2). 
 
O NH
S
  
 (R)-4-mesityloxazolidinethione: To a dry 250 mL round-bottom flask, 
under argon, was added amino alcohol 13 (4.86 g, 27.1 mmol) in 97 mL of 
CH2Cl2. To this solution was added triethylamine (9.4 mL, 67.8 mmol) and the 
solution was cooled to 0 °C. Thiophosgene (2.1 mL, 27.1 mmol) was diluted in 2 
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mL of CH2Cl2 and added slowly to the reaction vessel. The reaction mixture was 
stirred for 30 min at 0 °C and then quenched with 1 0% NaHSO4. After warming to 
room temperature, the layers were separated and the aqueous layer was 
extracted with CH2Cl2 (2x). The combined organic layers were washed with 1 M 
NH4OH, followed by saturated NaCl, dried over NaSO4, filtered, and concentrated 
under reduced pressure. The crude product was purified by flash column 
chromatography (30% EtOAc/Hex) to provide the product as a pale yellow foam 
(5.1 g, 85%). The product was crystallized by triturating with hexanes. 1H NMR 
(400 MHz, CDCl3): δ 2.25 (s, 3H), 2.34 (s, 6H), 4.53 (dd, 1H, J = 8.8, 8.8 Hz), 
4.96 (dd, 1H, J = 9.2, 10.8 Hz), 5.64 (dd, 1H, J = 8.8, 10.8 Hz), 6.87 (s, 2H). 13C 
NMR (100 MHz, CDCl3): δ 20.3, 20.7, 55.6, 74.9, 129.1, 131.0, 136.9, 138.7, 
189.3. IR (film): 3382, 3184, 2971, 2923, 1610, 1505, 1269, 1174, 1146 cm-1. 
ESI-MS: C12H15NOS [M+H] calc. 222.3, found 222.1, [M+Na] calc. 244.3, found 
244.1. [α]25D = -5.3° (c = 3.0, CH 2Cl2). 
 
O N
S O
 
 (R)-N-acetyloxazolidinethione 14: To a dry 500 mL round-bottom flask, 
under argon, was added the oxazolidinethione (7.82 g, 35.3 mmol) and 176 mL 
of CH2Cl2. The solution was cooled to 0 °C and triethylamine  (9.8 mL, 70.6 mmol) 
was added. The reaction mixture was stirred for 15 min at 0 °C and acetyl 
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chloride (3.8 mL, 53.0 mmol) was slowly added. The mixture was stirred for 15 
min at 0 °C, then warmed to room temperature and st irred for 20 min. The 
reaction was quenched with 10% NaHSO4 and the layers were separated. The 
aqueous layer was extracted with CH2Cl2 (2x) and the combined organic layers 
were dried over NaSO4, filtered, and concentrated under reduced pressure. The 
crude product was purified by flash column chromatography (15% EtOAc/Hex) to 
provide the product as a yellow foam (7.53 g, 81%). The foam was dissolved in 
CH2Cl2 and a crystal of the racemic N-acetyloxazolidinethione was used as a 
seed to induce crystallization. 1H NMR (400 MHz, CDCl3): δ 2.26 (s, 6H), 2.46 (s, 
3H), 2.78 (s, 3H), 4.39 (dd, 1H, J = 7.6, 8.8 Hz), 4.86 (dd, 1H, J = 10.0, 10.8 Hz), 
6.10 (dd, 1H, J = 7.2, 10.8 Hz), 6.87 (s, 2H). 13C NMR (100 MHz, CDCl3): δ 19.4, 
20.4, 20.6, 26.3, 57.9, 71.5, 129.6, 130.3, 131.7, 134.7, 137.2, 138.0, 170.7, 
186.3. IR (film): 3009, 2971, 2920, 2867, 1707, 1611, 1483, 1415, 1372, 1341, 
1311, 1239, 1181 cm-1. ESI-MS: C14H17NO2S [M+H] calc. 264.2, found 264.1. 
[α]25D = +75.3° (c = 5.55, CH 2Cl2). 
 
 
 Typical aldol procedure using N-acetyloxazolidinethione: To a dry 25 
mL round-bottom flask, under argon, was added N-acetyloxazolidinethione 14 
(0.263 g, 1.00 mmol) and 5 mL of CH2Cl2. The flask was cooled to −40 °C and 
titanium tetrachloride (neat, 0.22 mL, 2.00 mmol) was added and the reaction 
mixture was stirred for 5 min. Diisopropylethylamine (0.35 mL, 2.00 mmol) was 
then added and the solution was stirred for 2 h at −40 °C and was then cooled to 
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−78 °C, whereupon the freshly distilled aldehyde (n eat, 1.2 mmol) was added. 
The mixture was stirred for 4 h at −78 °C, then que nched with half saturated 
ammonium chloride and warmed to room temperature. The layers were 
separated and the aqueous layer was extracted with CH2Cl2 (2x). The combined 
organic layers were dried over NaSO4, filtered, and concentrated under reduced 
pressure. The crude product was purified by flash column chromatography (20% 
EtOAc/Hex). Yields and diastereoselectivities are listed in Table 1. 
 
O N
S O OH
 
 (R)-3-hydroxy-1-((R)-4-mesityl-2-thioxooxazolidin-3-yl)pentan-1-one: 1H 
NMR (400 MHz, CDCl3): δ 0.94 (dd, 3H, J = 7.2, 7.6 Hz), 1.48-1.60 (band, 2H), 
2.25 (s, 6H), 2.46 (s, 3H), 2.88 (brs, OH), 3.36 (dd, 1H, J = 2.4, 17.6 Hz), 3.51 
(dd, 1H, J = 9.2, 17.6 Hz), 3.91 (m, 1H), 4.39 (dd, 1H, J = 7.2, 9.2 Hz), 4.88 (dd, 
1H, J = 9.6, 10.8 Hz), 6.12 (dd, 1H, J = 7.2, 10.8 Hz), 6.86 (s, 1H), 6.87 (s, 1H). 
13C NMR (100 MHz, CDCl3): δ 9.73, 19.5, 20.5, 20.7, 29.2, 44.5, 58.1, 69.0, 71.8, 
129.7, 130.3, 131.8, 134.7, 137.0, 138.1, 173.5, 185.9. IR (film): 3472, 2967, 
2919, 2875, 1703, 1612, 1487, 1456, 1395, 1369, 1340, 1304, 1196 cm-1. ESI-
MS: C17H23NO3S [M+H] calc. 322.4, found 322.2, [M+Na] calc. 344.4, found 
344.1. [α]25D =  +21.5° (c = 3.7, CH 2Cl2). 
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 (R)-3-hydroxy-1-((R)-4-mesityl-2-thioxooxazolidin-3-yl)hexan-1-one: 1H 
NMR (400 MHz, CDCl3): δ 0.91 (dd, 3H, J = 6.8, 10.8 Hz), 1.37-1.52 (bands, 4H), 
2.52 (s, 6H), 2.46 (s, 3H), 2.88 (s, 1H), 3.35 (dd, 1H, J = 2.4, 18.0 Hz), 3.51 (dd, 
1H, J = 9.6, 18.0 Hz), 3.99 (s, 1H), 4.38 (dd, 1H, J = 7.2, 9.2 Hz), 4.88 (dd, 1H, J 
= 9.2, 10.8 Hz), 6.12 (dd, 1H, J = 7.2, 10.8 Hz), 6.86 (s, 1H), 6.87 (s, 1H). 13C 
NMR (100 MHz, CDCl3): δ 13.8, 18.5, 19.4, 20.5, 20.6, 38.3, 44.9, 58.1, 67.4, 
71.7, 129.7, 130.3, 131.7, 134.7, 137.0, 138.1, 173.5, 185.9. IR (film): 3458, 
2958, 2929, 2871, 1705, 1611, 1395, 1370, 1341, 1199, 1161 cm-1. ESI-MS: 
C18H25NO3S [M+H] calc. 336.5, found 336.2, [M+Na] calc. 358.5, found 358.2. 
[α]23D = +24.3° (c = 3.00, CH 2Cl2). 
 
O N
S O OH
 
 (S)-3-hydroxy-1-((R)-4-mesityl-2-thioxooxazolidin-3-yl)-4-methylpentan-
1-one: 1H NMR (400 MHz, CDCl3): δ 0.94 (dd, 6H, J = 5.6, 6.8 Hz), 1.71-1.76 (m, 
1H), 2.25 (s, 6H), 2.46 (s, 3H), 2.75 (d, 1H, J = 4.8 Hz), 3.32 (dd, 1H, J = 2.0, 
17.6 Hz), 3.56 (dd, 1H, J = 10.0, 17.6 Hz), 3.77 (m, 1H), 4.39 (dd, 1H, J = 7.2, 
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9.2 Hz), 4.87 (dd, 1H, J = 9.6, 11.2 Hz), 6.12 (dd, 1H, J = 7.2, 11.2 Hz), 6.86 (s, 
2H). 13C NMR (100 MHz, CDCl3): δ 17.7, 18.4, 19.6, 20.6, 20.7, 33.1, 42.1, 58.2, 
71.8, 72.5, 76.7, 129.8, 130.4, 131.8, 134.8, 137.1, 138.2, 174.0, 186.1. IR (film): 
3473, 2962, 2923, 2875, 1704, 1611, 1482, 1465, 1394, 1370, 1341, 1308, 1198, 
1161 cm-1. ESI-MS: C18H25NO3S [M+H] calc. 336.5, found 336.2, [M+Na] calc. 
358.5, found 358.2. [α]23D = +12.3° (c = 3.65, CH 2Cl2). 
 
O N
S O OH
 
 (R)-3-hydroxy-1-((R)-4-mesityl-2-thioxooxazolidin-3-yl)-5-methylhexan-
1-one: 1H NMR (400 MHz, CDCl3): δ 0.89 (t, 6H, J = 6.8 Hz), 1.19 (ddd, 1H, J = 
4.0, 8.8, 12.8 Hz), 1.52 (ddd, 1H, J = 5.2, 9.2, 14.4 Hz), 1.76-1.81 (bands, 1H), 
2.26 (s, 6H), 2.47 (s, 3H), 2.83 (s, 1H), 3.32 (dd, 1H, J = 2.0, 17.6 Hz), 3.51 (dd, 
1H, J = 9.6, 18.0 Hz), 4.05-4.08 (m, 1H), 4.39 (dd, 1H, J = 7.2, 9.2 Hz), 4.88 (dd, 
1H, J = 9.6, 10.8 Hz), 6.13 (dd, 1H, J = 7.2, 11.2 Hz), 6.87 (s, 1H), 6.88 (s. 1H). 
13C NMR (100 MHz, CDCl3): δ 19.5, 20.5, 20.7, 21.8, 23.1, 24.2, 45.3, 45.4, 58.1, 
65.8, 71.8, 129.7, 130.4, 131.8, 134.7, 137.0, 138.1, 173.6, 185.9. IR (film): 
3448, 2955, 2923, 2869, 1704, 1611, 1487, 1466, 1395, 1370, 1340, 1199, 1161 
cm-1. ESI-MS: C19H27NO3S [M+H] calc. 350.5, found 350.2, [M+Na] calc. 372.5, 
found 372.2. [α]24D = +36.1° (c = 1.5, CH 2Cl2). 
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 (S)-3-hydroxy-1-((R)-4-mesityl-2-thioxooxazolidin-3-yl)-3-
phenylpropan-1-one: 1H NMR (400 MHz, CDCl3): δ 2.22 (s, 3H), 2.27 (s, 3H), 
2.48 (s, 3H), 3.58 (dd, 1H, J = 2.4, 17.6 Hz), 3.93 (dd, 1H, J = 9.6, 17.6 Hz), 4.41 
(dd, 1H, J = 7.6, 9.6 Hz), 4.87 (dd, 1H, J = 9.6, 10.8 Hz), 5.13 (dd, 1H, J = 2.8, 
10.0 Hz), 6.13 (dd, 1H, J = 7.2, 11.2 Hz), 6.85 (s, 1H), 6.89 (s, 1H), 7.27-7.35 
(bands, 5H). 13C NMR (100 MHz, CDCl3): δ 19.5, 20.6, 20.7, 46.6, 58.2, 70.0, 
71.8, 125.8, 127.7, 128.5, 129.8, 130.2, 131.9, 138.3, 142.2, 172.8, 185.9. IR 
(film): 3464, 2971, 2919, 1704, 1607, 1482, 1452, 1391, 1370, 1341, 1200, 1158 
cm-1. ESI-MS: C21H23NO3S [M+H] calc. 370.5, found 370.2, [M+Na] calc. 392.5, 
found 392.2. [α]26D = +53.7° (c = 0.25, CH 2Cl2). 
 
O N
S O OH
 
 (S,E)-3-hydroxy-1-((R)-4-mesityl-2-thioxooxazolidin-3-yl)-5-phenylpent-
4-en-1-one: 1H NMR (400 MHz, CDCl3): δ 2.24 (s, 6H), 2.45 (s, 3H), 3.04 (s, 
1H), 3.53 (dd, 1H, J = 3.2, 17.6 Hz), 3.75 (dd, 1H, J = 8.8, 18.0 Hz), 4.37 (dd, 1H, 
J = 7.6, 9.2 Hz), 4.72 (m, 1H), 4.83 (dd, 1H, J = 9.6, 10.8 Hz), 6.09 (dd, 1H, J = 
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7.2, 10.8 Hz), 6.21 (dd, 1H, J = 6.0, 16.0 Hz), 6.59 (d, 1H, J = 16.0 Hz), 6.79 (s, 
1H), 6.87 (s, 1H), 7.23-7.35 (bands, 5H). 13C NMR (100 MHz, CDCl3): δ 19.5, 
20.6, 20.7, 44.9, 58.2, 68.5, 71.8, 126.5, 127.6, 128.4, 129.7, 130.2, 130.5, 
131.8, 134.7, 136.3, 137.0, 138.2, 172.5, 185.8. IR (film): 3430, 3022, 2971, 
2919, 2867, 1705, 1611, 1484, 1448, 1393, 1370, 1342, 1269, 1200, 1161 cm-1. 
ESI-MS: C23H25NO3S [M+H] calc. 396.2, found 396.2, [M+Na] calc. 418.2, found 
418.2. [α]24D = +62.5° (c = 1.25, CH 2Cl2). 
 
S N
O H
Cl
 
 Imine 22: To a dry 3-neck 1 L round-bottom flask, equipped with a 
mechanical stirrer and argon inlet, was added (R)-(+)-2-methyl-2-
propanesulfinamide (20.00 g, 165 mmol) and 330 mL of CH2Cl2. Anhydrous 
CuSO4 (165 g, 1.03 mol) was added in one portion followed by 
chloroacetaldehyde (198 mmol). The mixture was stirred at room temperature for 
24 h. The reaction mixture was filtered through a pad of celite and the filtrate was 
concentrated under reduced pressure. The crude product was purified by flash 
column chromatography (15% EtOAc/Hex to 25% EtOAc/Hex) to provide the 
product as a pale yellow oil (26.14 g, 87%). 1H NMR (400 MHz, CDCl3): δ 1.18 
(s, 1H), 4.29 (d, 2H, J = 4.8 Hz), 7.99 (ddd, 1H, J = 0.8, 4.8, 4.8 Hz). 13C NMR 
(100 MHz, CDCl3): δ 22.2, 43.5, 57.4, 162.4. IR (film): 2979, 2963, 2928, 2903 
2869, 1624, 1474, 1457, 1365, 1335, 1253, 1182, 1133 cm-1. ESI-MS: 
C6H12ClNOS [M+H] calc. 182.7, found 182.0. [α]27D = -295° (c = 2.90, CH 2Cl2). 
 72 
 
S NH
S
 
 (S)-4-mesitylthiazolidinethione 24: A dry 2 L round-bottom flask was 
charged with mesityl magnesium bromide (398 mmol, 5.0 equiv), prepared from 
10.0 g Mg turnings (0.41 mol), 60.0 mL 2-bromomesitylene (0.40 mol) and 139 
mL of dry ether. The flask was cooled to −78 °C and  imine 22 (14.50 g, 79.6 mol, 
1.0 equiv), dissolved in 265 mL of toluene, was slowly added to the solution and 
the reaction mixture was stirred for 3 h at −78 °C,  quenched with 4 N HCl (199 
mL, 796 mmol), warmed to room temperature and stirred for 3 h. The layers were 
separated, and the organic layer was extracted with H2O (2x). The aqueous 
layers were combined and cooled to 0 °C, upon which  50% NaOH was slowly 
added, while stirring, until the pH reached 11. H2O was added (approximately 
500 mL, to prevent an emulsion from forming) and the solution was extracted 
with ether (3x). The combined organic layers were dried over Na2SO4, filtered, 
and concentrated under reduced pressure. The residue was transferred to a 1 L 
round-bottom flask and 1 M KOH (398 mL, 398 mmol) was added. The reaction 
mixture was stirred for 10 min and carbon disulfide (24.0 mL, 398 mmol) was 
added. The reaction mixture was stirred for 30 min at room temperature, refluxed 
for 16 h, cooled to room temperature and extracted with CH2Cl2 (3x). The 
combined organic layers were dried over Na2SO4, filtered and concentrated 
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under reduced pressure. The crude product was purified by flash column 
chromatography (15% EtOAc/Hex to 100% CH2Cl2) to provide the product as a 
pale yellow solid (14.5 g, 77%). 1H NMR (400 MHz, CDCl3): δ 2.26 (s, 3H), 2.39 
(s, 6H), 3.63 (s, 1H), 3.65 (s, 1H), 5.83 (t, 1H, J = 10.4 H), 6.87 (s, 2H), 7.75 (brs, 
1H). 13C NMR (100 MHz, CDCl3): δ 20.5, 20.8, 37.5, 63.6, 129.3, 130.8, 136.6, 
138.6, 199.5. IR (film): 3333, 3130, 2965, 2923, 2858, 1610, 1482, 1383, 1288, 
1218, 1134 cm-1. ESI-MS: C12H15NS2 [M+H] calc. 238.4, found 238.0. [α]25D = 
+139° (c = 0.25, CH 2Cl2). 
S N
S O
 
 (S)-N-acetylthiazolidinethione 25 : To a dry 250 mL round-bottom flask, 
under argon, was added thiazolidinethione 24 (2.40 g, 10.1 mmol) and 51 mL 
THF. The solution was cooled to 0 ºC and 60% NaH in mineral oil (0.48 g, 12.1 
mmol) was slowly added. The reaction mixture was stirred for 15 min at 0 ºC, and 
acetyl chloride (0.86 mL, 12.1 mmol) was added dropwise. The reaction mixture 
was stirred for 30 min at 0 ºC, upon which it was warmed to room temperature 
and allowed to stir for 2 h. The reaction was quenched with saturated ammonium 
chloride and the layers were separated. The aqueous layer was extracted with 
EtOAc (2x) and the combined organic layers were dried over Na2SO4, filtered, 
and concentrated under reduced pressure. The crude product was purified by 
flash column chromatography (2% EtOAc/hexanes to 15% EtOAc/hexanes) to 
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provide N-acetylthiazolidinethione (2.63 g, 93%) as a yellow solid. 1H NMR (400 
MHz, CDCl3): δ 2.26 (s, 3H), 2.41 (s, 6H), 2.70 (s, 3H), 3.34 (dd, 1H, J = 10.0, 
11.2 Hz), 3.55 (dd, 1H, J = 10.4, 11.2 Hz), 6.36 (t, 1H, J = 10.4 Hz), 6.86 (s, 2H). 
13C NMR (100 MHz, CDCl3): δ 20.2, 20.8, 27.7, 32.4, 67.9, 132.6, 137.7, 171.9, 
201.4. IR (film):  3009, 2967, 2919, 2867, 1712, 1610, 1453, 1409, 1371, 1326, 
1266, 1217, 1136 cm-1. ESI-MS: C14H17NOS2 [M+Na] calc. 302.1, found 302.2. 
[α]25D = + 81.0° (c = 0.8, CH 2Cl2). 
 
 Typical aldol procedure using N-acetylthiazolidinethione: To a dry 25 
mL round-bottom flask, under argon, was added N-acetylthiazolidinethione 25 
(0.307 g, 1.10 mmol) and 5.2 mL of CH2Cl2. The solution was cooled to −78 °C 
and titanium tetrachloride (neat, 0.12 mL, 1.10 mmol) was added and stirred for 5 
min. Diisopropylethylamine (0.19 mL, 1.10 mmol) was added and the solution 
was stirred for 30 min at −78 °C, whereupon the fre shly distilled aldehyde (neat, 
1.0 mmol) was added dropwise. The mixture was stirred for 1 h at −78 °C, then 
quenched with half saturated ammonium chloride and warmed to room 
temperature. The layers were separated and the aqueous layer was extracted 
with CH2Cl2 (2x). The combined organic layers were dried over NaSO4, filtered, 
and concentrated under reduced pressure. The crude product was purified by 
flash column chromatography (10% EtOAc/Hex to 20% EtOAc/Hex). Yields and 
diastereoselectivities are listed in Table 2. 
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S N
S O OH
 
 (S)-3-hydroxy-1-((S)-4-mesityl-2-thioxothiazolidin-3-yl)pentan-1-one: 1H 
NMR (400 MHz, CDCl3): δ 0.91 (dd, 3H, J = 7.2, 7.6 Hz), 1.41-1.54 (bands, 2H), 
2.26 (s, 3H), 2.40 (s, 6H), 3.17 (dd, 1H, J = 2.4, 17.2 H), 3.33 (dd, 1H, J = 9.6, 
11.2 Hz), 3.48-3.61 (bands, 2), 3.76-3.82 (bands, 1H), 6.38 (t, 1H, J = 10.0 Hz), 
6.86 (s, 2H). 13C NMR (100 MHz, CDCl3): δ 9.73, 20.2, 20.8, 29.3, 32.5, 46.1, 
68.0, 69.6, 132.6, 137.9, 175.0, 201.7. IR (film): 3439, 2964, 2924, 2875, 1704, 
1610, 1456, 1371, 1325, 1258, 1177, 1129 cm-1. ESI-MS: C17H23NO2S2 [M+Na] 
calc. 360.5, found 360.2. [α]26D =  +101° (c = 0.65, CH 2Cl2). 
S N
S O OH
 
 (S)-3-hydroxy-1-((S)-4-mesityl-2-thioxothiazolidin-3-yl)hexan-1-one: 1H 
NMR (400 MHz, CDCl3): δ 0.88 (t, 3H, J = 7.2 Hz), 1.28-1.50 (bands, 4H), 2.25 
(s, 3H), 2.40 (s, 6H), 2.81 (d, 1H, J = 3.2 Hz), 3.16 (dd, 1H, J = 2.8, 17.6 Hz), 
3.33 (dd, 1H, J = 9.6, 11.2 Hz), 3.48-3.61 (bands, 2H), 3.87 (m, 1H), 6.38 (t, 1H, 
J = 10.0 Hz), 6.86 (s, 2H). 13C NMR (100 MHz, CDCl3): δ 13.9, 18.6, 20.2, 20.8, 
32.5, 38.6, 46.6, 67.9, 68.0, 132.6, 137.9, 175.0, 201.7. IR (film): 3460, 2957, 
2927, 2862, 1705, 1456, 1371, 1322, 1259, 1175, 1128 cm-1. ESI-MS: 
 76 
C18H25NO2S2 [M+H] calc. 352.5, found 352.2, [M+Na] calc. 374.5, found 374.2. 
[α]26D =  +108° (c = 0.25, CH 2Cl2). 
 
S N
S O OH
 
 (R)-3-hydroxy-1-((S)-4-mesityl-2-thioxothiazolidin-3-yl)-4-methylpentan-
1-one: 1H NMR (400 MHz, CDCl3): δ 0.90 (dd, 6H, J = 4.0, 6.8 Hz), 1.68 (m, 1H), 
2.26 (s, 3H), 2.40 (s, 6H), 2.84 (brs, 1H), 3.13 (dd, 1H, J = 1.6, 16.8 Hz), 3.33 
(dd, 1H, J = 9.6, 11.6 Hz), 3.51-3.67 (bands, 3H), 6.39 (t, 1H, J = 10.0 Hz), 6.86 
(s, 2H). 13C NMR (100 MHz, CDCl3): δ 17.6, 18.3, 20.2, 20.8, 32.5, 33.2, 43.6, 
68.1, 73.0, 132.6, 137.9, 175.4, 201.8. IR (film): 3460, 2960, 2927, 2873, 1698, 
1610, 1463, 1371, 1326, 1258, 1178, 1128 cm-1. ESI-MS: C18H25NO2S2 [M+H] 
calc. 352.5, found 352.2, [M+Na] calc. 374.5, found 374.2. [α]25D = +102° (c = 
0.55, CH2Cl2). 
S N
S O OH
 
 (S)-3-hydroxy-1-((S)-4-mesityl-2-thioxothiazolidin-3-yl)-5-methylhexan-
1-one: 1H NMR (400 MHz, CDCl3): δ 0.85 (dd, 6H, J = 6.4, 10.0 Hz), 1.10 (ddd, 
1H, J = 4.4, 8.8, 13.2), 1.46 (ddd, 1H, J = 5.2, 8.8, 14.4), 1.74 (m, 1H), 2.26 (s, 
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3H), 2.40 (s, 6H), 2.76 (brs, 1H), 3.15 (dd, 1H, J = 2.8, 17.2 Hz), 3.33 (dd, 1H, J 
= 9.6, 11.6 Hz), 3.47-3.62 (bands, 2H), 3.94 (m, 1H), 6.39 (t, 1H, J = 10.0 Hz), 
6.86 (s, 2H). 13C NMR (100 MHz, CDCl3): δ 20.2, 20.7, 21.8, 23.2, 24.3, 32.5, 
45.6, 47.1, 66.4, 68.0, 132.6, 137.8, 174.9, 201.6. IR (film): 3448, 2954, 2925, 
2868, 1709, 1610, 1462, 1370, 1324, 1259, 1174, 1127 cm-1. ESI-MS: 
C19H27NO2S2 [M+Na] calc. 388.6, found 388.3. [α]24D = +83.6° (c = 0.90, CH 2Cl2). 
 
S N
S O OH
 
 (R)-3-hydroxy-1-((S)-4-mesityl-2-thioxothiazolidin-3-yl)-3-
phenylpropan-1-one: 1H NMR (400 MHz, CDCl3): δ 2.24 (s, 3H), 2.36 (s, 6H), 
3.18 (brs, 1H), 3.27-3.38 (bands, 2H), 3.55 (dd, 1H, J = 11.2, 10.4 Hz), 3.91 (dd, 
1H, J = 9.6, 17.6), 4.98 (dd, 1H, J = 2.4, 9.2 Hz), 6.36 (t, 1H, J = 10.0 Hz), 6.82 
(s, 2H), 7.23-7.28 (bands, 5H). 13C NMR (100 MHz, CDCl3): δ 20.3, 20.8, 32.5, 
48.4, 68.1, 70.6, 125.8, 127.7, 128.5, 132.4, 137.9, 142.3, 174.0, 201.7. IR (film): 
3437, 3030, 2968, 2919, 2869, 1706, 1610, 1493, 1483, 1454, 1371, 1325, 1257, 
1183, 1129 cm-1. ESI-MS: C21H23NO2S2 [M+H] calc. 386.6, found 386.2, [M+Na] 
calc. 408.6, found 408.3. [α]26D = +60.0° (c = 0.55, CH 2Cl2). 
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S N
S O OH
 
 (R,E)-3-hydroxy-1-((S)-4-mesityl-2-thioxothiazolidin-3-yl)-5-phenylpent-
4-en-1-one: 1H NMR (400 MHz, CDCl3): δ 2.20 (s, 3H), 2.35 (s, 6H), 2.87 (s, 
6H), 3.28-3.33 (bands, 2H), 3.53 (dd, 1H, J = 10.4, 11.2 Hz), 3.76 (dd, 1H, J = 
8.4, 17.2 Hz), 4.60 (m, 1H), 6.11 (dd, 1H, J = 6.0, 16.0 Hz), 6.35 (t, 1H, J = 10.0 
Hz), 6.53 (d, 1H, J = 16.0 Hz), 6.77 (s, 2H), 7.19-7.31 (bands, 5H). 13C NMR (100 
MHz, CDCl3): δ 20.3, 20.8, 32.5, 46.8, 68.1, 69.0, 126.5, 127.7, 128.5, 129.8, 
130.6, 132.4, 136.4, 137.9, 173.8, 201.7. IR (film): 3027, 2962, 2917, 2867, 
1705, 1607, 1448, 1374, 1326, 1260, 1190, 1129 cm-1. ESI-MS: C23H25NO2S2 
[M+H] calc. 412.3, found 412.3, [M+Na] calc. 434.3, found 434.3. [α]26D = +20.2° 
(c = 0.20, CH2Cl2). 
  
S N
S O OTBS
 
 Protected aldol adduct: To a dry 100 mL round-bottom flask, under 
argon, was added aldol adduct 30a (1.90 g, 5.40 mmol) in 18 mL CH2Cl2. The 
flask was cooled to 0 °C and 2,6-lutidine (1.3 mL, 10.8 mmol) was added 
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followed by TBSOTf (1.49 mL, 6.48 mmol). The reaction mixture was stirred for 
30 min at 0 °C and reaction progress was monitored by TLC. The reaction 
mixture was quenched with saturated sodium bicarbonate, warmed to room 
temperature, and extracted with CH2Cl2 (3x). The combined organic layers were 
dried over Na2SO4 and concentrated under reduced pressure. The crude product 
was purified via flash column chromatography (2% EtOAc/Hex to 10% 
EtOAc/Hex) to provide the product as a yellow solid (2.48 g, 98%). 1H NMR (400 
MHz, CDCl3): δ 0.00 (d, 6H, J = 0.8 Hz), 0.71 (d, 3H, J = 6.8 Hz), 0.76 (d, 3H, J = 
6.8 Hz), 0.85 (s, 9H), 1.37 (m, 1H), 2.24 (s, 3H), 2.40 (s, 6H), 2.92 (dd, 1H, J = 
6.4, 10.0 Hz), 3.30 (dd, 1H, J = 9.2, 11.2 Hz), 3.57 (dd, 1H, J = 10.8, 11.2 Hz), 
3.73 (dd, 1H, J = 6.4, 18.0 Hz), 4.02 (ddd, 1H, J = 3.2, 6.4, 9.2 Hz), 6.36 (dd, 1H, 
J = 8.8, 10.0 Hz), 6.84 (s, 2H). 13C NMR (100 MHz, CDCl3): δ -4.88, -4.89, 16.4, 
18.1, 18.5, 20.3, 20.8, 25.6, 32.4, 32.8, 44.1, 68.0, 72.7, 132.9, 137.8, 140.4, 
173.5, 201.2. IR (film): 2956, 2927, 2849, 1713, 1616, 1469, 1371, 1327, 1254, 
1175, 1127 cm-1. ESI-MS: C24H39NO2S2Si [M+H] calc. 466.8, found 466.3, 
[M+Na] calc. 488.6, found 488.3. [α]23D = +108° (c = 0.10, CH 2Cl2). 
 
O OTBS
H
 
 Aldehyde 31a: To a dry 100 mL round-bottom flask, under argon, was 
added the protected aldol adduct (0.75 g, 1.61 mmol) in 16 mL CH2Cl2. The flask 
was cooled to -78 °C, upon which DIBAL (1 M in hexa nes) was added dropwise 
until the reaction mixture became colorless (~3.2 mL, 3.22 mmol). The reaction 
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mixture was immediately quenched with saturated potassium sodium tartrate, 
warmed to room temperature, and vigorously stirred for 1 h. 5 mL Et2O was 
added and the reaction mixture was stirred 5 min, then extracted with Et2O (3x). 
The combined organic layers were dried over Na2SO4 and concentrated under 
reduced pressure. The crude product was purified via flash column 
chromatography (2% EtOAc/Hex) to provide the product as a pale yellow oil 
(0.307 g, 83%). 1H NMR (400 MHz, CDCl3): δ 0.03 (d, 6H, J = 10.8 Hz), 0.85-
0.92 (bands, 15H), 1.77 (m, 1H), 2.41 (ddd, 1H, J = 2.0, 4.4, 15.6 Hz), 2.50 (ddd, 
1H, J = 2.8, 7.2, 15.6 Hz), 4.01 (ddd, 1H, J = 4.8, 4.8, 7.2 Hz), 9.79 (dd, 1H, J = 
2.0, 3.2 Hz). 13C NMR (100 MHz, CDCl3): δ -4.67, -4.56, 17.2, 18.0, 25.7, 34.0, 
47.2, 72.4, 202.6. IR (film): 2958, 2931, 2888, 2858, 2718, 1728, 1472, 1388, 
1370, 1254, 1218 cm-1. ESI-MS: C12H26O2Si [M+H] calc. 231.4, found 231.2. 
[α]22D = -4.54° (c = 1.05, CH 2Cl2). 
S N
S O OH OTBS
 
 (3S,5R)-5-(tert-butyldimethylsilyloxy)-3-hydroxy-1-((S)-4-mesityl-2-
thioxothiazolidin-3-yl)-6-methylheptan-1-one 32a: See “Typical aldol 
procedure using N-acetylthiazolidinethione.” One modification made to this 
procedure involves quenching with half-saturated sodium bicarbonate instead of 
ammonium chloride. The crude product was purified by flash column 
chromatography (5% EtOAc/Hex to 15% EtOAc/Hex) to provide the product as a 
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mixture of diastereomers (93% yield, 90:10 dr) as a yellow oil. 1H NMR (400 
MHz, CDCl3): δ 0.03 (s, 6H), 0.64 (d, 3H, J = 6.8 Hz), 0.81 (d, 3H, J = 7.2 Hz), 
0.85 (s, 9H), 1.21-1.26 (bands, 1H), 1.39-1.45 (bands, 1H), 1.70 (m, 1H), 2.21 (s, 
3H), 2.38 (s, 6H), 3.15 (dd, 1H, J = 5.6, 17.6 Hz), 3.30 (dd, 1H, J = 10.0, 11.2 
Hz), 3.53-3.61 (bands, 2H), 3.67 (m, 1H), 4.07 (m, 1H), 6.36 (t, 1H, J = 10.0 Hz), 
6.81 (s, 2H). 13C NMR (100 MHz, CDCl3): δ -4.74, -4.41, 16.6, 17.2, 17.8, 20.2, 
20.6, 25.7, 25.8, 32.3, 32.5, 37.3, 47.3, 67.0, 67.8, 75.7, 75.8, 132.5, 137.6, 
173.7, 201.0. IR (film): 3481, 2956, 2928, 2895, 2856, 1708, 1611, 1577, 1462, 
1370, 1329, 1258, 1177, 1129 cm-1. ESI-MS: C26H43NO3S2Si [M+H] calc. 510.8, 
found 510.4, [M+Na] calc. 532.8, found 532.4. [α]21D = +65.5° (c = 0.45, CH 2Cl2). 
 
S N
S O OH OTBS
 
 (3R,5R)-5-(tert-butyldimethylsilyloxy)-3-hydroxy-1-((R)-4-mesityl-2-
thioxothiazolidin-3-yl)-6-methylheptan-1-one (33a): See “Typical aldol 
procedure using N-acetylthiazolidinethione.” One modification made to this 
procedure involves quenching with half-saturated sodium bicarbonate instead of 
ammonium chloride. The crude product was purified by flash column 
chromatography (5% EtOAc/Hex to 15% EtOAc/Hex) to provide the product as a 
mixture of diastereomers (91% yield, 95:5 dr) as a yellow oil. 1H NMR (400 MHz, 
CDCl3): δ -0.02 (s, 3H), 0.2 (s, 3H), 0.75 (d, 3H, 6.4 Hz), 0.82-0.90 (bands, 12H), 
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1.26-1.45 (bands, 2H), 1.75 (m, 1H), 2.23 (s, 3H), 2.39 (s, 6H), 3.14 (dd, 1H, J = 
5.6, 16.8 Hz), 3.30 (t, 2H, J = 10.0 Hz), 3.45 (dd, 1H, J = 8.0 Hz, 17.2 Hz), 3.53-
3.64 (bands, 2H), 4.08 (m, 1H), 6.35 (t, 1H, J = 10.0 Hz), 6.82 (s, 2H). 13C NMR 
(100 MHz, CDCl3): δ -4.83, -4.74, 16.9, 17.7, 18.5, 20.1, 20.5, 25.7, 32.4, 32.9, 
38.2, 47.3, 65.1, 67.7, 73.8, 73.9, 132.2, 137.3, 174.3, 200.9. IR (film): 3488, 
2956, 2928, 2895, 2856, 1705, 1611, 1577, 1463, 1386, 1370, 1331, 1296, 1258, 
1186, 1129 cm-1. ESI-MS: C26H43NO3S2Si [M+H] calc. 510.8, found 510.4, 
[M+Na] calc. 532.8, found 532.3, [2M+Na] calc. 1041.8, found 1041.5. [α]21D = -
71.9° (c = 0.15, CH 2Cl2). 
 
S N
S
Bn
O OTBS
Me
 
 Protected aldol adduct: To a dry 100 mL round-bottom flask, under argon, 
was added aldol adduct 30b (2.95 g, 5.40 mmol) in 29 mL CH2Cl2. The flask was 
cooled to 0 °C and 2,6-lutidine (2.0 mL, 17.5 mmol)  was added followed by 
TBSOTf (2.41 mL, 10.5 mmol). The reaction mixture was stirred for 30 min at 0 
°C and reaction progress was monitored by TLC. The reaction mixture was 
quenched with saturated sodium bicarbonate, warmed to room temperature, and 
extracted with CH2Cl2 (3x). The combined organic layers were dried over Na2SO4 
and concentrated under reduced pressure. The crude product was purified via 
flash column chromatography (2% EtOAc/Hex to 10% EtOAc/Hex) to provide the 
product as a yellow solid (3.66 g, 94%). 1H NMR (400 MHz, CDCl3): δ 0.06 (s, 
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3H), 0.07 (s, 3H), 0.82 (d, 3H, J = 6.8 Hz), 0.90 (s, 12H), 1.24 (d, 3H, J = 6.4 Hz), 
1.63 (m, 1H), 2.87 (d, 1H, J = 11.6 Hz), 3.03 (dd, 1H, J = 4.8, 4.8 Hz), 3.21 (dd, 
1H, J = 3.2, 12.8 Hz), 3.33 (dd, 1H, J = 7.2, 11.6 Hz), 3.88 (dd, 1H, J = 2.4, 7.2 
Hz), 4.47 (m, 1H), 5.21 (ddd, 1H, J = 3.6, 6.4, 10.4 Hz), 7.24-7.34 (bands, 5H). 
13C NMR (100 MHz, CDCl3): δ -3.80, -3.73, 15.1, 17.1, 18.4, 19.8, 26.1, 32.0, 
33.4, 36.5, 42.6, 69.1, 78.5, 127.2, 128.9, 129.5, 136.6, 177.5, 200.6. IR (film):  
2957, 2927, 2893, 2858, 1694, 1456, 1363, 1339, 1253, 1190, 1162, 1116 cm-1. 
ESI-MS: C23H37NO2S2Si [M+H] calc. 452.8, found 452.3, [M+Na] calc. 474.8, 
found 474.2. [α]23D = -213° (c = 0.20, CH 2Cl2). 
 
O OTBS
H
Me
 
 Aldehyde 31b: To a dry 100 mL round-bottom flask, under argon, was 
added the protected aldol adduct (0.60 g, 1.33 mmol) in 13 mL CH2Cl2. The flask 
was cooled to -78 °C, upon which DIBAL (1 M in hexa nes) was added dropwise 
until the reaction mixture became colorless (~2.7 mL, 2.66 mmol). The reaction 
mixture was immediately quenched with saturated potassium sodium tartrate, 
warmed to room temperature, and vigorously stirred for 1 h. 5 mL Et2O was 
added and the reaction mixture was stirred 5 min, then extracted with Et2O (3x). 
The combined organic layers were dried over Na2SO4 and concentrated under 
reduced pressure. The crude product was purified via flash column 
chromatography (2% EtOAc/Hex to 10% EtOAc/Hex) to provide the product as a 
pale yellow oil (0.268 g, 82%). 1H NMR (400 MHz, CDCl3): δ 0.01 (s, 3H), 0.07 
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(s, 3H), 0.89-0.93 (bands, 15H), 1.09 (d, 3H, J = 8.0 Hz), 1.81 (m, 1H), 2.50 (m, 
1H), 3.90 (t, 1H, J = 4.4 Hz), 9.78 (s, 1H). 13C NMR (100 MHz, CDCl3): δ -4.21, -
4.03, 8.59, 18.3, 19.7, 25.9, 32.2, 50.6, 76.4, 205.5. IR (film):  2958, 2884, 2858, 
1728, 1472, 1387, 1254, 1100 cm-1. ESI-MS: C13H28O2Si [M+H] calc. 245.6, 
found 245.2, [M+Na] calc. 267.5, found 267.2. [α]22D = -59.1° (c = 0.40, CH 2Cl2). 
 
S N
S O OH OTBS
Me
 
 (3R,4S,5S)-5-(tert-butyldimethylsilyloxy)-3-hydroxy-1-((S)-4-mesityl-2-
thioxothiazolidin-3-yl)-4,6-dimethylheptan-1-one 32b: To a dry 25 mL round-
bottom flask, under argon, was added N-acetylthiazolidinethione 25 (0.474 g, 
1.70 mmol) and 6 mL of CH2Cl2. The solution was cooled to −78 °C and titanium 
tetrachloride (neat, 0.19 mL, 1.70 mmol) was added and stirred for 5 min. 
Diisopropylethylamine (0.30 mL, 1.70 mmol) was added and the solution was 
stirred for 30 min at −78 °C, upon which the freshl y prepared aldehyde (neat, 
1.13 mmol) was added dropwise. The mixture was stirred for 1 h at −78 °C, then 
quenched with half saturated sodium bicarbonate and warmed to room 
temperature. The layers were separated and the aqueous layer was extracted 
with CH2Cl2 (2x). The combined organic layers were dried over NaSO4, filtered, 
and concentrated under reduced pressure. The crude product was purified by 
flash column chromatography (5% EtOAc/Hex to 10% EtOAc/Hex) to provide the 
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product as a mixture of diastereomers (0.537 g, 91%, 97:3 dr) as a yellow oil. 1H 
NMR (400 MHz, CDCl3): δ 0.02 (d, 6H, J = 10.0 Hz), 0.75 (d, 3H, J = 6.8 Hz), 
0.84-0.93 (bands, 15H), 1.49 (m, 1H), 1.76 (m, 1H), 2.25 (s, 3H), 2.40 (s, 6H), 
2.68 (s, 1H), 3.13 (dd, 1H, J = 3.6, 17.6 Hz), 3.34 (dd, 1H, J = 10.0, 11.6 Hz), 
3.47 (dd, 1H, J = 4.0, 4.4 Hz), 3.55-3.68 (bands, 2H), 3.96 (m, 1H), 6.39 (t, 1H, J 
= 10.0 Hz), 6.85 (s, 2H). 13C NMR (100 MHz, CDCl3): δ -3.96, -3.65, 9.86, 17.5, 
18.4, 19.4, 20.2, 20.7, 26.1, 32.2, 32.4, 40.4, 45.1, 68.0, 70.4, 78.6, 132.5, 137.9, 
174.8, 201.5. IR (film):  3545, 2956, 2928, 2856, 1705, 1611, 1462, 1371, 1329, 
1257, 1178, 1128 cm-1. ESI-MS: C27H45NO3S2Si [M+H] calc. 524.9, found 524.3, 
[M+Na] calc. 546.9, found 546.3. [α]22D = +52.2° (c = 0.70, CH 2Cl2). 
 
S N
S O OH OTBS
Me
 
 (3S,4S,5S)-5-(tert-butyldimethylsilyloxy)-3-hydroxy-1-((R)-4-mesityl-2-
thioxothiazolidin-3-yl)-4,6-dimethylheptan-1-one 33b: To a dry 25 mL round-
bottom flask, under argon, was added N-acetylthiazolidinethione 21 (0.419 g, 
1.50 mmol) and 5 mL of CH2Cl2. The solution was cooled to −78 °C and titanium 
tetrachloride (neat, 0.16 mL, 1.50 mmol) was added and stirred for 5 min. 
Diisopropylethylamine (0.26 mL, 1.50 mmol) was added and the solution was 
stirred for 30 min at −78 °C, upon which the freshl y prepared aldehyde (neat, 1.0 
mmol) was added dropwise. The mixture was stirred for 1 h at −78 °C, then 
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quenched with half saturated sodium bicarbonate and warmed to room 
temperature. The layers were separated and the aqueous layer was extracted 
with CH2Cl2 (2x). The combined organic layers were dried over NaSO4, filtered, 
and concentrated under reduced pressure. The crude product was purified by 
flash column chromatography (5% EtOAc/Hex to 10% EtOAc/Hex) to provide the 
product as a mixture of diastereomers (0.482 g, 92%, 92:8 dr) as a yellow oil. 1H 
NMR (400 MHz, CDCl3): δ -0.06 (s, 3H), 0.03 (s, 3H), 0.79 (d, 3H, J = 6.8 Hz), 
0.85-0.92 (bands, 15H), 1.72 (m, 2H), 2.25 (s, 3H), 2.41 (s, 6H), 3.25-3.36 
(bands, 3H), 4.46 (dd, 1H, J = 9.6, 16.8 Hz), 3.58 (dd, 1H, J = 10.4, 11.2 Hz), 
3.72 (m, 2H), 6.34 (t, 1H, J = 10.0 Hz), 6.85 (s, 2H). 13C NMR (100 MHz, CDCl3): 
δ -4.26, -4.11, 10.9, 18.3, 19.5, 19.6, 20.2, 20.7, 26.1, 32.2, 32.5, 41.4, 44.4, 
68.1, 70.2, 76.3, 132.4, 137.7, 175.3, 201.7. IR (film):  3460, 2956, 2927, 2855, 
1696, 1611, 1462, 1385, 1369, 1327, 1258, 1185, 1128 cm-1. ESI-MS: 
C27H45NO3S2Si [M+H] calc.524.9, found 524.3, [M+Na] calc. 546.9, found 546.3. 
[α]22D = -73.4° (c = 0.30, CH 2Cl2). 
 
























































Chapter 4 
Experimental Information and NMR spectra for Chapter 2 
 
 Methods and Materials: Infrared (IR) spectra were obtained using a 
Jasco 460 Plus Fourier transform infrared spectrometer and values reported in 
cm-1. Proton and carbon nuclear magnetic resonance (1H and 13C NMR) spectra 
were recorded on the Bruker 400 (1H at 400 MHz; 13C at 100 MHz). Optical 
rotations were determined using a Jasco P1010 polarimeter. Thin layer 
chromatography (TLC) was conducted on silica gel F254 TLC plates purchased 
from Scientific Adsorbents, Inc. Flash column chromatography was carried out 
using silica gel (32 to 63 µm) purchased from Scientific Adsorbents, Inc. Diethyl 
ether (Et2O), tetrahydrofuran (THF), dichloromethane (CH2Cl2), and toluene were 
dried by being passed through a column of neutral alumina under nitrogen 
immediately prior to use. Alkylamines were distilled from calcium hydride 
immediately prior to use. All other reagents and solvents were used as received 
from the manufacturer, unless otherwise specified. All air and water sensitive 
reactions were performed in flasks flame dried under positive flow argon and 
conducted under an argon atmosphere. 
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 Aldol adduct 78: To a dry 1L round-bottom flask, under argon, was added 
N-acetylthiazolidinethione 76 (17.4g, 65.5 mmol) in 360 mL CH2Cl2. The solution 
was cooled to 0 °C and titanium tetrachloride (neat , 7.50 mL, 68.6 mmol) was 
added dropwise. The thick suspension was stirred for 5 min upon which ()-
sparteine was added (15.0 mL, 65.5 mmol). The dark red solution was stirred for 
20 min at 0 °C, then cooled to -78 °C upon which N-methyl-2-pyrrolidinone (6.3 
mL, 65.5 mmol) was added. The mixture was stirred 10 min at -78 °C and 
aldehyde 77 (neat, 17.6 g, 72.0 mmol) was added dropwise. The reaction mixture 
was stirred 1 h at -78 °C then warmed to 0 °C for 1  h upon which the reaction 
was quenched with half-saturated ammonium chloride. The layers were 
separated and the aqueous layer was extracted with CH2Cl2 (2x). The combined 
organic layers were dried over NaSO4, filtered, and concentrated under reduced 
pressure. The crude product was purified by flash column chromatography (10% 
EtOAc/Hex to 25% EtOAc/Hex) to provide the product (34.0 g, 93%) as a yellow 
oil. 1H NMR (400 MHz, CDCl3): δ 1.06 (s, 21H), 1.27 (d, 3H, J = 6.8 Hz), 1.64 (m, 
4H), 2.89 (d, 1H, J = 11.6 Hz), 3.05 (m, 1H), 3.25 (dd, 1H, J = 3.2 Hz, 12.8 Hz), 
3.74 (m, 2H), 3.98 (m, 1H), 3.52 (m, 1H), 5.33 (m, 1H), 7.23 (m, 5H). 13C NMR 
(100 MHz, CDCl3): δ 10.8, 11.9, 18.0, 29.5, 31.8, 32.1, 36.7, 43.9, 63.5, 69.1, 
72.4, 127.2, 128.9, 129.5, 136.5, 177.9, 201.2. IR (film):   3413, 3087, 3063, 
3030, 2942, 2865, 2727, 1955, 1883, 1813, 1697, 1604, 1584, 1496, 1456, 1341, 
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1292, 1261, 1191, 1164 cm-1. ESI-MS: C26H43NO3S2Si [M+Na] calc.532.3, found 
532.3, [2M+Na] calc. 1041.5, found 1041.5. [α]21D = -15.0° (c = 1.10, CH 2Cl2). 
 
 
 Protected aldol adduct: To a dry 500 mL round-bottom flask, under argon, 
was added aldol adduct 78 (33.0 g, 64.7 mmol) in 129 mL CH2Cl2. The solution 
was cooled to 0 °C upon which triethylamine (12.0 m L, 84.1 mmol) was added, 
followed by distilled trimethylsilyl chloride (9.9 mL, 77.7 mmol). 4-
dimethylaminopyridine (0.396 g, 3.24 mmol) was added and the reaction mixture 
was stirred for 2 h at 0 °C. The reaction was quenc hed with saturated sodium 
bicarbonate and extracted with CH2Cl2 (3x). The combined organic layers were 
dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude 
product was purified by flash column chromatography (100% Hex to 5% 
EtOAc/Hex to 10% EtOAc/Hex) to provide the product (34.8 g, 92%) as a yellow 
oil. 1H NMR (400 MHz, CDCl3): δ 0.12 (s, 9H), 1.06 (s, 21H), 1.24 (d, 6.8 Hz), 
1.57 (m, 4H), 2.89 (d, 11.6 Hz), 3.33 (m, 2H), 3.69 (m, 2H), 3.99 (m, 1H), 4.56 
(qn, 1H, J = 6.4 Hz), 5.17 (sp, 1H, J = 3.6 Hz), 7.32 (m, 5H). 13C NMR (100 MHz, 
CDCl3): δ 0.44, 12.0, 12.8, 18.1, 29.2, 31.4, 32.2, 36.5, 44.8, 63.3, 69.6, 74.7, 
127.2, 128.9, 129.5, 136.7, 177.0, 200.9. IR (film): 3028, 2943, 2892, 2865, 
2725, 1699, 1496, 1456, 1363, 1341, 1292, 1252, 1191, 1164, 1104 cm-1. ESI-
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MS: C29H51NO3S2Si2 [M+Na] calc. 604.3, found 604.3. [α]21D = +183.8° (c = 0.7, 
CH2Cl2).    
 
 
 Aldehyde 75: To a dry 1L round-bottom flask equipped with an addition 
funnel, under argon, was added the protected aldol adduct (25.1 g, 43.1 mmol) in 
287 mL CH2Cl2. The yellow solution was cooled to -78 °C, upon wh ich DIBAL (1 
M in hexanes) was added dropwise until the reaction mixture became colorless 
(~86 mL, 86.2 mmol). The reaction mixture was immediately quenched with 
saturated potassium sodium tartrate, warmed to room temperature, and 
vigorously stirred for 1 h. 20 mL Et2O was added and the reaction mixture was 
stirred 5 min, then extracted with Et2O (3x). The combined organic layers were 
dried over Na2SO4 and concentrated under reduced pressure. The crude product 
was purified via flash column chromatography (5% EtOAc/Hex to 10% 
EtOAc/Hex) to provide the product as a pale yellow oil (13.1 g, 81%). 1H NMR 
(400 MHz, CDCl3): δ 0.08 (s, 9H), 1.04 (s, 24H), 1.52 (m, 4H), 2.42 (m, 1H), 3.67 
(m, 2H), 4.11 (m, 1H), 9.71 (s, 1H). 13C NMR (100 MHz, CDCl3): δ 0.31, 7.79, 
11.9, 18.0, 29.4, 31.2, 51.5, 63.0, 71.9, 120.0, 204.9. IR (film):  2944, 2893, 
2867, 2713, 1728, 1463, 1383, 1252, 1200, 1104 cm-1. ESI-MS: C19H42O3Si2 
[M+Na] calc. 397.2, found 397.2. [α]20D = -28.9° (c = 1.75, CH 2Cl2).  
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 β-Ketophosphonate 124: To a dry 2L round-bottom flask equipped with 
an addition funnel, under argon, was added dimethyl methylphosphonate (43 mL, 
400 mmol) in 332 mL THF. The solution was cooled to -78 °C and n-BuLi (1.6 M, 
247 mL, 395 mmol) was added dropwise. The white suspension was stirred 1h at 
-78 °C upon which methyl β-benzyloxypropionate (19.5 g, 100 mmol) was added 
in 168 mL THF. The reaction mixture was stirred 1 h -78 °C at which point it was 
quenched with saturated ammonium chloride and warmed to room temperature. 
The layers were separated and the aqueous layer was extracted with Et2O (3x). 
The combined organic layers were dried over Na2SO4, filtered, and concentrated 
under reduced pressure. The crude product was purified via flash column 
chromatography (85% EtOAc/Hex to 100% EtOAc) to provide the product as a 
colorless oil (20.3 g, 71%). 1H NMR (400 MHz, CDCl3): δ 2.77 (t, 2H, J = 6.0 Hz), 
3.02 (d, 2H, J = 22.4 Hz), 3.62 (m, 8H), 4.37 (s, 2H), 7.19 (m, 5H). 13C NMR (100 
MHz, CDCl3): δ 40.8, 42.1, 43.9, 52.8, 52.9, 64.8, 73.0, 127.6, 128.3, 138.0, 
200.2, 200.3. IR (film):  3474, 3062, 3030, 2956, 2909, 2856, 1715, 1496, 1455, 
1397, 1368, 1259, 1185 cm-1. ESI-MS: C13H19O5P [M+Na] calc. 309.1, found 
309.1, [M+Cs] calc. 419.0, found 419.0, [2M+Na] calc. 595.2, found 595.2. [α]20D 
= +0.89° (c = 1.25, CH 2Cl2).      
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 Enone 125: To a dry 2L round-bottom flask, under argon, was added β-
ketophosphonate 124 (18.2 g, 63.6 mmol) in 114 mL THF. To the solution was 
added anhydrous barium hydroxide (6.53 g, 38.1 mmol) and the mixture was 
stirred 30 min at room temperature. Aldehyde 75 (17.0 g, 45.4 mmol) was added 
in 126 mL of 40:1 THF:H2O, followed by an additional 154 mL of 40:1 THF:H2O. 
The reaction mixture was stirred 1 h at room temperature and was then diluted 
with EtOAc and filtered over celite. The solution was washed with saturated 
sodium bicarbonate and the aqueous layer was extracted with EtOAc (4x). The 
combined organic layers were dried over Na2SO4, filtered, and then concentrated 
under reduced pressure. The crude product was purified via flash column 
chromatography (5% EtOAc/Hex to 10% EtOAc/Hex) to provide the product as a 
colorless oil (21.9 g, 90%). 1H NMR (400 MHz, CDCl3): δ 0.12 (s, 9H), 1.06 (s, 
24H), 1.34-1.65 (bands, 4H), 2.45 (m, 1H), 2.89 (t, 2H, J = 6.4 Hz), 3.66 (m, 3H), 
3.80 (t, 2H, J = 6.4 Hz), 4.53 (s, 2H), 6.11 (d, 1H, J = 16.4 Hz), 6.87 (dd, 1H, J = 
7.6 Hz, 16.0 Hz), 7.39 (m, 5H). 13C NMR (100 MHz, CDCl3): δ 0.48, 12.0, 14.7, 
18.0, 29.2, 30.6, 40.0, 42.6, 63.3, 65.5, 73.2, 75.5, 127.6, 127.7, 128.4, 130.2, 
138.2, 150.4, 198.5. IR (film): 3031, 2944, 2892, 2866, 2729, 2360, 1697, 1673, 
1628, 1496, 1463, 1366, 1251, 1201, 1102 cm-1. ESI-MS: C30H54O4Si2 [M+Na] 
calc. 557.4, found 557.4, [2M+Na] calc. 1091.8, found 1091.8. [α]21D = -29.9° (c = 
0.90, CH2Cl2). 
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 Hydroxyketone 126:  
   i) To a dry 2L round-bottom flask, under argon, was added CuI 
(1.56 g, 8.18 mmol) in 400 mL THF. The solution was cooled to -50 °C and MeLi 
(1.6 M, 5.1 mL, 8.18 mmol) was added dropwise. The yellow suspension was 
stirred 5 min upon which freshly distilled HMPA (82 mL, 470 mmol) was added, 
followed by DIBAL (1 M, 106 mL, 106 mmol). The mixture was stirred 30 min at   
-50 °C, at which point enone 125 (21.9 g, 40.9 mmol) was added in 200 mL THF. 
The reaction mixture was stirred 1 h at -50 °C. The  dry ice bath was removed 
and 100 mL 1N HCl was added. The mixture was diluted with Et2O and allowed 
to stir for 5 min. The layers were separated and the organic layer was washed 
with 1 N HCl (2x) then with H2O (2x). The combined organic layers were dried 
over MgSO4, filtered, and then concentrated under reduced pressure. The crude 
product (a mixture of the TMS-protected ketone and TMS-deprotected ketone) 
was passed through a silica plug (10% EtOAc/Hex to 50% EtOAc/Hex) then 
taken on to the next step. 
   ii) To a dry 1 L round-bottom flask, under argon, was added the 
mixture of TMS-protected ketone and TMS-deprotected ketone (21.3 g) in 400 
mL anhydrous MeOH. Ammonium fluoride (29.0 g, 793 mmol, 20 equiv.) was 
added and the reaction mixture was stirred 2 h at room temperature. The 
reaction was quenched with saturated sodium bicarbonate and diluted with Et2O. 
The layers were separated and the organic layer was washed with brine. The 
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combined aqueous layers were extracted with CH2Cl2 (2x). The combined 
organic layers were dried over MgSO4, filtered, and concentrated under reduced 
pressure. The crude product was purified via flash column chromatography 
(100% Hex to 20% EtOAc/Hex to 50%EtOAc/Hex) to provide the product as a 
pale yellow oil (17.1 g, 90% over 2 steps). 1H NMR (400 MHz, CDCl3): δ 0.89 (m, 
3H), 1.08 (s, 21H), 1.38-1.88 (bands, 8H), 2.10 (m, 1H), 2.51 (m, 1H), 2.73 (m, 
1H), 3.49-3.78 (bands, 4H), 4.10 (m, 1H), 4.53 (m, 3H), 7.29 (m, 5H). 13C NMR 
(100 MHz, CDCl3): δ 10.9, 11.9, 12.0, 14.0, 18.0, 26.5, 26.6, 29.3, 29.6, 29.9, 
30.1, 31.4, 38.1, 40.3, 41.5, 42.8, 63.5, 63.7, 65.4, 66.6, 71.0, 73.2, 73.4, 74.1, 
96.0, 127.7, 128.4, 137.7, 209.8. IR (film): 3481, 2942, 2892, 2866, 2359, 1715, 
1456, 1386, 1246, 1101 cm-1. ESI-MS: C27H48O4Si [M+Na] calc. 487.3, found 
487.3, [2M+Na] calc. 951.6, found 951.6. [α]21D = +1.56° (c = 2.20, CH 2Cl2).   
 
 
 Enol ether 127: To a dry 100 mL round-bottom flask, under argon, was 
added activated 4 Å powdered molecular sieves (30 mL), hydroxyketone 126 
(1.59 g, 3.42 mmol), and 34 mL toluene. CSA (0.556 g, 0.7 mmol) was added 
and the reaction mixture was allowed to stir 2.5 h at room temperature. The 
reaction was quenched with triethylamine, filtered to remove the molecular 
sieves, and washed with saturated sodium bicarbonate. The layers were 
separated and the aqueous layer was extracted with Et2O (2x). The combined 
organic layers were dried over Na2SO4, filtered, and concentrated under reduced 
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pressure. The crude product was purified via flash column chromatography 
(5%EtOAc/Hex doped with triethylamine) to provide the product as a colorless oil 
(1.45 g, 95%). The product was immediately carried on to the next step due to its 
instability. 1H NMR (400 MHz, CDCl3): δ 0.91 (m, 3H), 1.09 (s, 21H), 1.49-1.73 
(bands, 5H), 1.92 (m, 1H), 2.22 (m, 1H), 2.35 (t, 2H, J = 6.4 Hz), 3.61 (t, 2H, J = 
6.8 Hz), 3.67-3.82 (bands, 3H), 4.91 (s, 1H), 4.54 (s, 2H), 7.30 (m, 5H). 13C NMR 
(100 MHz, CDCl3): δ 12.0, 13.5, 18.0, 27.0, 28.5, 29.3, 29.5, 34.8, 63.3, 68.1, 
72.8, 78.0, 95.0, 127.4, 127.6, 128.3, 138.6, 150.1. IR (film): 2942, 2924, 2892, 
2865, 1678, 1462, 1383, 1246, 1207, 1170, 1101 cm-1. ESI-MS: C27H46O3Si 
[M+Na] calc. 469.3, found 469.3. [α]21D = -23.9° (c = 2.25, CH 2Cl2).    
 
 
 Thioacetal 130: To a dry 500 mL round-bottom flask, under argon, was 
added enol ether 127 (1.43 g, 3.20 mmol) in 32 mL CH2Cl2. The solution was 
cooled to -78 °C upon which freshly prepared “aceto ne-free” DMDO1 (90 mL, 
4.48 mmol) was added. TLC showed complete consumption of starting material. 
The dry ice bath was removed and the solvents were removed via an argon 
purge. 32 mL CH2Cl2 was added and the solution was cooled to 0 °C. Eth anethiol 
(12 mL, 160 mmol) was added, followed by Zn(OTf)2 (0.116 g, 0.320 mmol). The 
reaction mixture was stirred 45 min at 0 °C, at whi ch point the reaction was 
quenched with triethylamine. Excess ethanethiol was removed under an argon 
                                                 
1
 Crimmins, M. T.; McDougall, P. J.; Ellis, J. M. Org. Lett. 2006, 8, 4079. 
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purge and the remaining solvent was removed under reduced pressure. The 
crude product was purified via flash column chromatography (5% EtOAc/Hex 
doped with triethylamine to 10%EtOAc/Hex doped with triethylamine) to provide 
the product as a colorless oil (1.39 g, 83%). 1H NMR (400 MHz, CDCl3): δ 0.94 
(m, 3H), 1.07 (s, 21H), 1.23 (t, 4H, J = 7.6 Hz), 1.45-1.70 (bands, 5H), 1.90 (m, 
1H), 2.05 (m, 3H), 2.32 (m, 2H), 3.63-3.81 (bands, 3H), 4.09 (m, 2H), 4.61 (m, 
3H), 7.33 (m, 5H). 13C NMR (125 MHz, CDCl3): δ 12.0, 12.8, 14.6, 18.8, 28.8, 
29.9, 31.9, 35.1, 41.1, 63.3, 67.5, 69.1, 72.1, 73.5, 94.0, 128.0, 128.1, 128.6, 
136.9. IR (film): 3413, 3090, 3063, 3032, 2958, 2941, 2892, 2866, 1731, 1455, 
1386, 1258, 1210 cm-1. ESI-MS: C29H52O4SSi [M+Na] calc. 547.3, found 547.3, 
[2M+Na] calc. 1071.6, found 1071.6. [α]21D =  -55.4° (c = 0.30, CH 2Cl2). 
 
 
 
 Protected thioacetal: To a dry 250 mL round-bottom flask equipped with 
an addition funnel, under argon, was added alcohol 130 (1.08 g, 2.06 mmol) in 
21 mL THF. The solution was cooled to -78 °C and tr iethylsilyl chloride (2.1 mL, 
12.3 mmol) was added. KHMDS (0.5 M, 25 mL, 12.6 mmol) was added dropwise. 
The reaction mixture was stirred 15 min at -78 °C u pon which it was quenched 
with saturated sodium bicarbonate and warmed to room temperature. The layers 
were separated and the aqueous layer was extracted with Et2O (2x) and the 
combined organic layers were dried over Na2SO4, filtered, and concentrated 
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under reduced pressure. The crude product was purified via flash column 
chromatography (100% Hex to 5% EtOAc/Hex to 10% EtOAc/Hex) to provide the 
product as a cloudy light yellow oil (1.27 g, 96%). 1H NMR (400 MHz, CDCl3): δ 
0.56 (m, 6H), 0.94 (t, 12H, J = 8.0 Hz), 1.09 (s, 21H), 1.23 (m, 7H), 1.39-1.65 
(bands, 7H), 1.86 (brs, 2H), 2.20 (m, 2H), 2.38 (m, 4H), 3.72 (m, 4H), 3.96 (m, 
1H), 4.04 (dd, 1H, J = 1.2 Hz, 11.6 Hz), 4.52 (m, 2H), 7.30 (m, 5H). 13C NMR 
(100 MHz, CDCl3): δ 5.18, 6.91, 12.0, 12.8, 14.7, 18.0, 19.6, 28.8, 29.9, 32.1, 
37.0, 39.3, 63.4, 66.7, 68.3, 72.1, 73.1, 92.1, 127.5, 127.8, 128.3, 138.6. IR 
(film): 3088, 3064, 3031, 2943, 2867, 2729, 2239, 1944, 1804, 1496, 1462, 1414, 
1382, 1362, 1290, 1260, 1242, 1207, 1107 cm-1. ESI-MS: C35H66O4SSi2 [M+Na] 
calc. 661.4, found 661.4. [α]20D = -0.51° (c = 0.60, CH 2Cl2).   
 
 
 Protected pyran 131: To a dry 1 L round-bottom flask, under argon, was 
added the thioacetal (4.36 g, 6.82 mmol) in 68 mL CH2Cl2. The solution was 
cooled to -78 °C and m-CPBA (purified by washing with pH 7.5 buffer, 6.12 g, 
35.5 mmol) was added. The reaction mixture was stirred 2 h at -78 °C. The dry 
ice bath was replaced with an ice water bath and 3 portions of AlMe3 (8 mL per 
aliquot, 28.0 mmol per aliquot) were added at 30 min intervals at 0 °C. 30 min 
after the last aliquot was added, an additional 3.7 mL AlMe3 (13.0 mmol) was 
added. After stirring 30 min at 0 °C, the reaction was quenched slowly by 
dropwise addition of saturated potassium sodium tartrate. The mixture was 
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stirred vigorously overnight at which point it was extracted with CH2Cl2 (2x). The 
combined organic layers were dried over MgSO4, filtered, the concentrated under 
reduced pressure. The crude product was purified via flash column 
chromatography (2% EtOAc/Hex to 5% EtOAc/Hex) to provide the product as a 
cloudy pale yellow oil (3.62 g, 90%). 1H NMR (400 MHz, CDCl3): δ 0.57 (qr, 6H, J 
= 7.6 Hz, 15.6 Hz), 0.95 (t, 12H, J = 8.0 Hz), 1.08 (s, 21H), 1.12 (s, 3H), 1.22-
1.60 (bands, 5H), 1.80 (m, 3H), 2.01 (m, 1H), 3.54 (m, 1H), 3.68 (m, 5H), 4.51 (s, 
2H), 7.35 (m, 5H). 13C NMR (100 MHz, CDCl3): δ 1.03, 5.21, 6.95, 12.0, 12.5, 
15.1, 18.1, 29.2, 29.8, 32.9, 36.6, 40.4, 63.5, 66.4, 69.5, 71.0, 73.0, 76.4, 127.4, 
127.7, 128.3, 138.8. IR (film): 3030, 2943, 2867, 1732, 1462, 1414, 1382, 1241, 
1102 cm-1. ESI-MS: C34H64O4Si2 [M+Na] calc. 615.4, found 615.4. [α]20D = -5.42° 
(c = 1.00, CH2Cl2).  
 
 
 Hydroxypyran: To a dry 500 mL round-bottom flask, under argon, was 
added benzyl ether 131 (3.61 g, 6.09 mmol) in 61 mL THF. The solution was 
cooled to 0 °C and 61 mL 0.5 M Na/naphtholide (prep ared by adding 1.04 g Na 
to a solution of 6.35 g naphthalene in 90 mL THF in a dry 250 mL round-bottom 
flask, under argon, cooled to 0 °C and sonicating 2  h). TLC showed immediate 
consumption of starting material. The reaction was quenched with water and the 
layers were separated. The aqueous layer was extracted with Et2O (2x) and the 
combined organic layers were dried over Na2SO4, filtered, and concentrated 
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under reduced pressure. The crude product was purified via flash column 
chromatography (2% EtOAc/Hex to 10% EtOAc/Hex) to provide the product as a 
colorless oil (2.61 g, 85%). 1H NMR (400 MHz, CDCl3): δ 0.56 (m, 6H), 0.95 (m, 
12H), 1.05 (s, 21H), 1.20 (s, 3H), 1.49-1.65 (bands, 5H), 1.81 (m, 4H), 3.66 (m, 
4H), 3.82 (m, 3H). 13C NMR (100 MHz, CDCl3): δ 5.14, 6.86, 12.0, 12.4, 15.3, 
18.0, 29.2, 29.5, 32.5, 36.3, 41.1, 59.6, 63.2, 68.3, 71.7, 80.1, 128.3. IR (film): 
3523, 2943, 2888, 2868, 1731, 1463, 1415, 1383, 1240, 1102 cm-1. ESI-MS: 
C27H58O4Si2 [M+Na] calc. 525.3, found 525.3, [M+K] calc. 541.3, found 541.3, 
[2M+Na] calc. 1027.7, found 1027.7, [2M+K] calc. 1043.6, found 1043.6. [α]20D = -
7.43° (c = 0.80, CH 2Cl2). 
 
 
 Aldehyde 132: To a dry 250 mL round-bottom flask equipped with an 
addition funnel, under argon, was added oxalyl chloride (2 M, 3.9 mL, 7.78 mmol) 
and 17 mL CH2Cl2. The solution was cooled to -78 °C and anhydrous D MSO 
(0.74 mL, 10.4 mmol) in 17 mL CH2Cl2 was added dropwise. The mixture was 
stirred 15 min at -78 °C upon which the alcohol (2. 61 g, 5.19 mmol) in 18 mL 
CH2Cl2 was added dropwise. The reaction was stirred 30 min at -78 °C then 
triethylamine (neat, 3.6 mL, 26.0 mmol) was added dropwise. The mixture was 
stirred 30 min at -78 °C then 30 min at 0 °C upon w hich it was transferred to a 
separatory funnel and washed with 60 mL each of H2O, 1 N HCl, saturated 
sodium bicarbonate, then brine. Each wash was back-extracted with CH2Cl2 (2x). 
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The combined organic layers were dried over Na2SO4, filtered, and concentrated 
under reduced pressure. The crude product was passed through a short silica 
plug with 100% CH2Cl2, concentrated under reduced pressure, and then 
immediately subjected to the next reaction (2.56 g, 98%, yellow oil). 
 
 
 TES protected olefin: To a dry 200 mL round-bottom flask, under argon, 
was added methylenetriphenylphosphine bromide (7.29 g, 20.4 mmol) in 30 mL 
THF. The mixture was cooled to 0 °C and potassium tert-butoxide (1 M, 15 mL, 
15.3 mmol) was added. The bright yellow mixture was stirred 30 min at 0 °C 
upon which aldehyde 132 (2.56 g, 5.11 mmol) was added in 21 mL THF. The 
reaction was stirred 30 min at 0 °C then quenched w ith water. The layers were 
separated and the aqueous layer was extracted with Et2O (2x). The combined 
organic layers were dried over Na2SO4, filtered, and concentrated under reduced 
pressure. The crude product was purified via flash column chromatography (2% 
EtOAc/Hex to 5% EtOAc/Hex) to provide the product as a colorless oil (2.31 g, 
91%). 1H NMR (400 MHz, CDCl3): δ 0.58 (m, 6H), 0.96 (m, 12H), 1.07 (s, 24H), 
1.23-1.55 (bands, 3H), 1.61 (m, 2H), 1.78 (m, 2H), 2.27 (dddd, 2H, J = 7.2 Hz, 
13.6 Hz, 34.8 Hz, 48.4 Hz), 3.56 (m, 1H), 3.67 (m, 3H), 5.04 (m, 2H), 5.98 (ddd, 
1H, J = 7.2 Hz, 17.2 Hz, 34.4 Hz). 13C NMR (100 MHz, CDCl3): δ 5.28, 6.93, 
12.0, 12.5, 15.1, 18.0, 29.2, 29.8, 32.9, 36.9, 45.2, 63.5, 68.7, 71.1, 116.6, 134.9. 
IR (film): 3074, 2942, 2892, 2867, 2730, 1824, 1730, 1640, 1463, 1414, 1382, 
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1240, 1103 cm-1. ESI-MS: C28H58O3Si2 [M+H] calc. 499.4, found 499.4, [M+Na] 
calc. 521.4, found 521.4. [α]20D =  -5.17° (c = 1.05, CH 2Cl2).   
 
 Hydroxypyran 133: To a 250 mL round-bottom flask was added the silyl 
ether (2.31 g, 4.63 mmol) in 46 mL 5:1 THF:H2O. A solution of CSA in EtOH (0.1 
M, 9 mL, 0.926 mmol) was added and the reaction mixture was stirred 3 h at 
room temperature. The reaction was quenched with saturated sodium 
bicarbonate and the layers were separated. The aqueous layer was extracted 
with Et2O (2x) and the combined organic layers were dried over Na2SO4, filtered, 
and concentrated under reduced pressure. The crude product was purified via 
flash column chromatography (100% Hexanes to 10% EtOAc/Hex to 25% 
EtOAc/Hex) to provide the product as a very pale yellow oil (1.38 g, 78%). 1H 
NMR (400 MHz, CDCl3): δ 0.92 (d, 3H, J = 7.2 Hz), 1.05 (s, 21H), 1.11 (s, 3H), 
1.20-1.53 (bands, 3H), 1.64-1.85 (bands, 5H), 2.30 (ddd, 2H, J = 13.6 Hz, 21.6 
Hz, 29.2 Hz), 3.55 (m, 1H), 3.67 (m, 3H), 5.07 (m, 2H), 5.98 (m, 1H). 13C NMR 
(100 MHz, CDCl3): δ 12.0, 12.3, 15.0, 18.0, 29.1, 29.7, 32.9, 36.1, 45.8, 63.4, 
68.1, 71.3, 76.6, 117.2, 134.8. IR (film): 3371, 3074, 2942, 2892, 2866, 1640, 
1464, 1383, 1246, 1220 cm-1. ESI-MS: C22H44O3Si  [M+Na] calc. 407.3, found 
407.3. [α]20D = -19.2° (c = 0.85, CH 2Cl2). 
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 Glycolic acid: To a dry 25 mL round-bottom flask, under argon, was added 
NaH (60% in mineral oil, 0.324 g, 8.10 mmol). The mineral oil was removed by 
washing with pentane. 1 mL THF was added and the mixture was cooled to 0 °C 
upon which a solution of bromoacetic acid (0.450 g, 3.24 mmol) in 1 mL THF 
dropwise. The mixture was stirred 10 min at 0 °C th en 30 min at room 
temperature, and then cooled back to 0 °C. Alcohol 133 (1.04 g, 2.70 mmol) was 
added in 2 mL THF and the reaction mixture was warmed to room temperature. 
1.4 mL DMF was added and the reaction was stirred 3 days at room temperature 
then quenched with saturated ammonium chloride. The layers were separated 
and the aqueous layer was acidified with 1 N HCl to pH = 1 then was extracted 
with Et2O (3x). The combined aqueous layers were dried over Na2SO4, filtered, 
and concentrated under reduced pressure. The crude product was purified via 
flash column chromatography (100% Hexanes to 15% EtOAc/Hex to 85% 
EtOAc/Hex) to provide the product as a light yellow oil (0.865 g, 72%, 84% 
brsm). 1H NMR (400 MHz, CDCl3): δ 0.92 (d, 3H, J = 7.2 Hz), 1.06 (m, 21H), 1.16 
(s, 3H), 1.32-1.55 (bands, 3H), 1.60-1.87 (bands, 5H), 2.35 (dddd, 2H, J = 7.2 
Hz, 14.0 Hz), 3.49 (dd, 1H, J = 5.2 Hz, 12.0 Hz), 3.60 (m, 1H), 3.69 (m, 2H), 4.10 
(m, 2H), 5.04 (s, 1H), 5.08 (m, 1H), 5.93 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 
12.0, 12.3, 16.0, 29.0, 29.6, 32.3, 32.5, 45.2, 63.4, 66.3, 71.3, 76.1, 77.4, 117.1, 
134.6, 175.2. IR (film): 3079, 2942, 2892, 2866, 1733, 1640, 1464, 1383, 1245, 
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1129 cm-1. ESI-MS: C24H46O5Si  [M+Na] calc. 465.3, found 465.3. [α]20D =  -17.5° 
(c = 0.85, CH2Cl2). 
 
 Glycolate 115: To a dry 100 mL round-bottom flask, under argon, was 
added the glycolic acid (0.601 g, 1.36 mmol) in 10 mL THF. The solution was 
cooled to -78 °C and triethylamine (0.21 mL, 1.50 m mol) was added followed by 
dropwise addition of freshly distilled pivaloyl chloride (0.18 mL, 1.50 mmol). The 
mixture was warmed to 0 °C for 1 h then cooled back  to -78 °C. 
 In a separate, dry 25 mL round-bottom flask, under argon, was added the 
oxazolidinone (0.211 g, 1.63 mmol) in 4.5 mL THF. The solution was cooled to -
78 °C and n-BuLi (1.6 M, 0.98 mL, 1.56 mmol) was added dropwise. The mixture 
was stirred 1 h at -78 °C. 
 The lithiated oxazolidinone was added to the mixed anhydride at -78 °C. 
The reaction was stirred 1 h at -78 °C then 45 min at 0 °C upon which it was 
quenched with saturated ammonium chloride. The layers were separated and the 
aqueous layer was extracted with Et2O (2x). The combined organic layers were 
dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude 
product was purified via flash column chromatography (10% EtOAc/Hex to 25% 
EtOAc/Hex) to provide the product as a colorless oil (0.637 g, 85%). 1H NMR 
(400 MHz, CDCl3): δ 0.87 (m, 9H), 1.01 (s, 21H), 1.06-1.21 (m, 5H), 1.32-1.53 
(m, 3H), 1.58 (m, 1H), 1.65-1.87 (m, 3H), 2.33 (m, 3H), 3.38 (m, 1H), 3.54 (m, 
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1H), 3.64 (m, 2H), 4.03 (m, 1H), 4.21 (m, 1H), 4.30 (dd, 1H, J = 2.3 Hz, 8.4 Hz), 
4.39 (m, 1H), 4.60 (m, 1H), 4.98 (s, 1H), 5.01 (m, 1H), 5.93 (m, 1H). 13C NMR 
(100 MHz, CDCl3): δ 11.9, 12.3, 14.5, 16.0, 17.8, 18.0, 28.1, 29.1, 29.7, 32.4, 
32.6, 45.3, 58.1, 63.4, 68.9, 71.2, 76.2, 76.7, 117.0, 134.8, 154.0, 170.2. IR 
(film): 2966, 2942, 2896, 2866, 1785, 1722, 1639, 1464, 1389, 1302, 1257, 1210, 
1100 cm-1. ESI-MS: C30H55NO6Si  [M+Na] calc. 576.4, found 576.4, [2M+Na] 
calc. 1129.8, found 1129.8. [α]20D = +19.7° (c = 0.90, CH 2Cl2). 
 
 Nitrile: To a dry 100 mL round-bottom flask, under argon, was added 
NaHMDS (0.83 M, 2.3 mL, 1.89 mmol) in 4 mL THF. The solution was cooled to  
-78 °C and glycolate 115 (0.697 g, 1.26 mmol) in 9 mL THF was added dropwise. 
The mixture was stirred 30 min at -78 °C upon which  bromoacetonitrile was 
added (0.35 mL, 5.04 mmol) dropwise. The reaction was stirred 1 h at -78 °C 
then quenched with saturated ammonium chloride and warmed to room 
temperature. The layers were separated and the aqueous layer was extracted 
with Et2O (2x). The combined organic layers were dried over Na2SO4, filtered, 
and concentrated under reduced pressure. The crude product was purified via 
flash column chromatography (10% EtOAc/Hex to 15% EtOAc/Hex) to provide 
the product as a colorless oil (0.389 g, 52%). 1H NMR (400 MHz, CDCl3): δ 0.90 
(m, 6H), 0.95 (d, 3H, J = 6.8 Hz), 1.06 (m, 21H), 1.16 (s, 3H), 1.41 (m, 3H), 1.65 
(m, 2H), 1.85 (m, 3H), 2,77 (m, 2H), 3.44 (dd, 1H, J = 4.8 Hz, 11.6 Hz), 3.57-3.75 
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(m, 3H), 4.32 (dd, 1H, J = 7.6 Hz, 10.4 Hz), 4.42 (m, 1H), 4.51 (m, 1H), 5.01 (m, 
1H), 5.05 (s, 1H), 5.41 (m, 1H), 5.97 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 12.0, 
12.2, 14.8, 16.0, 17.8, 18.0, 23.0, 28.3, 29.0, 29.7, 32.1, 32.5, 44.8, 58.6, 63.4, 
64.3, 69.6, 71.3, 75.6, 75.8, 116.8, 135.0, 153.8, 169.5. IR (film): 2962, 2942, 
2896, 2866, 1781, 1720, 1464, 1389, 1248, 1207, 1105 cm-1. ESI-MS: 
C32H56N2O6Si  [M+Na] calc. 615.4, found 615.4, [M+Cs] calc. 725.3, found 725.3. 
[α]20D = +37.0° (c = 0.30, CH 2Cl2). 
 
 Alcohol 134: To a 50 mL round-bottom flask was added the oxazolidinone 
(0.386 g, 0.651 mmol) in 7 mL 3:1 THF:H2O. Sodium borohydride (0.037 g, 0.977 
mmol) was added and the reaction was stirred 1 h at room temperature. The 
reaction was quenched with saturated sodium potassium tartrate and stirred 30 
min at room temperature. The layers were separated and the aqueous layer was 
extracted with EtOAc (2x). The combined organic layers were dried over Na2SO4, 
filtered, and concentrated under reduced pressure. The crude product was 
purified via flash column chromatography (15% EtOAc/Hex to 30% EtOAc/Hex) 
to provide the product as a colorless oil (0.266 g, 87%). 1H NMR (400 MHz, 
CDCl3): δ 0.93 (d, 3H, J = 6.8 Hz), 1.06 (m, 21H), 1.13 (s, 3H), 1.32-1.55 (m, 3H), 
1.62 (m, 1H), 1.72 (brs, 1H), 1.85 (m, 4H), 2.31 (m, 2H), 2.58 (m, 2H), 3.52 (m, 
1H), 3.68 (m, 6H), 5.05 (s, 1H), 5.10 (m, 1H), 6.01 (m, 1H). 13C NMR (100 MHz, 
CDCl3): δ 12.0, 12.4, 16.3, 18.0, 21.3, 29.0, 29.6, 32.5, 33.0, 45.3, 62.9, 63.4, 
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71.3, 72.8, 74.3, 75.8, 117.0,117.6, 134.8. IR (film): 3464, 3074, 2942, 2893, 
2866, 2253, 1725, 1639, 1464, 1384, 1245, 1223, 1100 cm-1. ESI-MS: 
C26H49NO4Si  [M+Na] calc. 490.3, found 490.3. [α]19D =  -10.5° (c = 1.10, CH 2Cl2). 
 
 
 Aldehyde: To a dry 250 mL round-bottom flask equipped with an addition 
funnel, under argon, was added oxalyl chloride (2 M, 0.43 mL, 0.854 mmol) and 
2 mL CH2Cl2. The solution was cooled to -78 °C and anhydrous D MSO (0.08mL, 
1.14 mmol) in 2 mL CH2Cl2 was added dropwise. The mixture was stirred 15 min 
at -78 °C upon which alcohol 134 (0.266 g, 0.569 mmol) in 2 mL CH2Cl2 was 
added dropwise. The reaction was stirred 30 min at -78 °C then triethylamine 
(neat, 0.40 mL, 2.85 mmol) was added dropwise. The mixture was stirred 30 min 
at -78 °C then 30 min at 0 °C upon which it was tra nsferred to a separatory 
funnel and washed with 20 mL each of H2O, 1 N HCl, saturated sodium 
bicarbonate, then brine. Each wash was back-extracted with CH2Cl2 (2x). The 
combined organic layers were dried over Na2SO4, filtered, and concentrated 
under reduced pressure. The crude product was passed through a short silica 
plug with 100% CH2Cl2, concentrated under reduced pressure, and then 
immediately subjected to the next reaction (0.251 g, 95%, yellow oil). 
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 Diene 114:  
 Preparation of salt-free methylenetriphenylphosphorane: To a dry 50 mL 
round-bottom flask, under argon, was added 0.193 g 60% NaH, which was 
washed with pentane to remove the mineral oil, in 11 mL THF. To the solution 
was added 2.0 g methylenetriphenylphosphine bromide and the mixture was 
stirred overnight at room temperature, filtered, and then concentrated under 
reduced pressure. The ylide was store under argon until used. 
 Preparation of diene 114: To a dry 50 mL round-bottom flask, under argon, 
was added the ylide (0.208 g, 0.754 mmol) in 11 mL THF. The mixture was 
cooled to 0 °C and the aldehyde (0.251 g, 0.539 mmo l) was added in 5 mL THF. 
The reaction was stirred 1 h at 0 °C the quenched w ith half-saturated sodium 
bicarbonate. The layers were separated and the aqueous layer was extracted 
with EtOAc (3x) (brine was used to break up any emulsion that may have 
formed). The combined organic layers were dried over Na2SO4, filtered, and 
concentrated under reduced pressure. Due to the instability of the product, the 
crude product was passed through a short silica plug (2% EtOAc/Hex doped with 
triethylamine to 5% EtOAc/Hex doped with triethylamine) to give the pure product 
(0.176 g, 70%), then taken on immediately to the next step. 
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 Bicycle 135: To a dry 100 mL round-bottom flask, under argon, was added 
diene 114 (0.176 g, 0.379 mmol) in 38 mL degassed CH2Cl2.  To this solution 
was added Grubb’s 2nd generation catalyst (0.016 g, 0.0190 mmol). The reaction 
mixture was stirred 3 h at room temperature, upon which it was opened to air and 
allowed to sit overnight at room temperature. The mixture was then concentrated 
under reduced pressure and the crude product was purified via flash column 
chromatography (5% EtOAc/Hex to 10% EtOAc/Hex) to give the purified product 
(0.136 g, 82%) as a colorless oil. 1H NMR (400 MHz, CDCl3): δ 0.95 (d, 3H, J = 
6.8 Hz), 1.05 (m, 21H), 1.19 (s, 3H), 1.36-1.43 (m, 2H), 1.46-1.53 (m, 1H), 1.57-
1.64 (m, 1H), 1.69-1.88 (bands, 3H), 2.32 (m, 2H), 2.59 (m, 2H), 3.45-3.77 
(bands, 4H), 4.31 (m, 1H), 5.51-5.56 (m, 1H), 5.84 (m, 1H). 13C NMR (100 MHz, 
CDCl3): δ 12.0, 12.3, 15.9, 18.0, 25.3, 29.0, 29.6, 32.8, 34.8, 43.9, 63.3, 71.3, 
74.3, 75.0, 80.5, 117.5, 130.1, 130.5. IR (film): 2958, 2940, 2888, 2866, 1728, 
1463, 1383, 1276, 1102 cm-1. ESI-MS: C25H45NO3Si  [M+Na] calc. 458.3, found 
458.3. [α]19D = -41.0° (c = 0.05, CH 2Cl2). 
 
 Diol 159: To a 100 mL round-bottom flask was added olefin 135 (0.132 g, 
0.303 mmol) in 5 mL 4:1 acetone:H2O. N-Methylmorpholine-N-oxide (0.089 g, 
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0.758 mmol) was added followed by osmium tetroxide (0.0151 mmol of a 20 
mg/mL solution in water). The reaction was stirred overnight at room temperature 
upon which it was quenched with sodium sulfite (0.100 mg) and stirred 30 min at 
room temperature. EtOAc was added and the layers were separated. The 
aqueous layer was extracted with EtOAc (5x) and the combined organic layers 
were dried over Na2SO4, filtered, and concentrated under reduced pressure. The 
crude product was purified via flash column chromatography (50% EtOAc/Hex to 
85% EtOAc/Hex) to provide the product as a colorless oil (0.137 g, 96%). 1H 
NMR (400 MHz, CDCl3): δ 0.95 (d, 3H, J = 7.2 Hz), 1.06 (m, 21H), 1.23 (s, 3H), 
1.37-1.44 (m, 2H), 1.45-1.53 (m, 1H), 1.58-1.68 (m, 2H), 1.68-1.80 (m, 3H), 1.85 
(m, 1H), 2.21 (m, 2H), 2.63 (dddd, 2H, J = 5.2 Hz, 16.8 Hz, 34.0 Hz), 2.77 (m, 
1H), 3.68 (m, 4H), 3.91 (m, 2H), 4.15 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 
12.0, 12.4, 16.4, 18.0, 23.9, 29.0, 29.5, 32.3, 33.8, 44.9, 63.4, 68.8, 70.9, 74.3, 
76.0, 77.5, 117.7. IR (film): 3425, 2942, 2896, 2866, 1726, 1463, 1384, 1247, 
1103 cm-1. ESI-MS: C25H47NO5Si  [M+H] calc. 470.3, found 470.3, [M+Na] calc. 
492.3, found 492.3, [M+Cs] calc. 602.2, found 602.2. [α]19D = -6.19° (c = 0.75, 
CH2Cl2). 
 
 Acetonide 113: To a dry 25 mL round-bottom flask, under argon, was 
added diol 159 (0.089 g, 0.189 mmol) and 3.3 mL 10:1 CH2Cl2:2-
 166 
methoxypropene. PPTS (0.019 g, 0.0758 mmol) was added and the mixture was 
stirred 45 min at room temperature. The reaction was quenched with saturated 
sodium bicarbonate and the layers were separated. The aqueous layer was 
extracted with CH2Cl2 (2x) and the combined organic layers were dried over 
Na2SO4. filtered, and concentrated under reduced pressure. The crude product 
was purified via flash column chromatography (2% EtOAc/Hex to 5% EtOAc/Hex 
to 10% EtOAc/Hex) to provide the product as a pale yellow oil (0.074 g, 77%). 1H 
NMR (400 MHz, CDCl3): δ 0.96 (d, 3H, J = 6.8 Hz), 1.05 (s, 21H), 1.14 (s, 3H), 
1.32 (s, 3H), 1.41 (s, 3H), 1.43 (m, 2H), 1.50 (m, 2H), 1.57-1.92 (bands, 5H), 
2.29 (m, 1H), 2.48 (dd, 1H, J = 8.0 Hz, 16.8 Hz), 2.76 (m, 1H), 3.45 (m, 1H), 3.67 
(m, 4H), 3.92 (m, 1H), 4.50 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 12.0, 12.5, 
14.4, 18.0, 22.9, 24.2, 27.3, 28.9, 29.6, 32.6, 33.5, 44.0, 63.4, 70.8, 73.6, 74.1, 
76.6, 79.1, 83.4, 108.8, 117.8.  
 
 Aldehyde: To a dry 25 mL round-bottom flask, under argon, was added 
nitrile 113 (0.032 g, 0.0598 mmol) and 2 mL toluene. The solution was cooled to   
-78 °C and DIBAL (1 M, 0.12 mL, 0.120 mmol) was add ed dropwise. The 
reaction mixture was stirred 1 h at -78 °C and then  quenched with saturated 
sodium potassium tartrate. The mixture was stirred vigorously at room 
temperature for 1 h. The layers were separated and the aqueous layer was 
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extracted with Et2O (2x). The combined organic layers were dried over Na2SO4, 
filtered, and concentrated under reduced pressure. The crude product was 
purified via flash column chromatography (5% EtOAc/Hex to 10% EtOAc/Hex) to 
provide the product as a pale yellow oil (0.030 g, 94%). 1H NMR (400 MHz, 
CDCl3): δ 0.98 (d, 3H, J = 7.2 Hz), 1.05 (s, 21H), 1.14 (s, 3H), 1.33 (s, 3H), 1.40 
(s, 5H), 1.42-1.76 (bands, 7H), 1.86 (m, 1H), 1.94 (m, 1H), 2.28 (m, 1H), 2.58 (m, 
1H), 2.78 (m, 1H), 3.47 (m, 1H), 3.68 (m, 4H), 3.94 (m, 2H), 4.50 (m, 1H), 9.80 
(s, 1H). 13C NMR (100 MHz, CDCl3): δ 12.0, 12.5, 14.3, 18.0, 24.3, 27.3, 29.0, 
32.7, 33.8, 44.2, 47.7, 63.4, 70.8, 73.8, 74.3, 76.2, 79.7, 83.0, 108.4, 200.6. 
 
 
 
 β-hydroxyphosphonate: To a dry 23 mL round-bottom flask, under argon, 
was added dimethyl methylphosphonate (0.05 mL, 0.468 mmol) in 1 mL THF. 
The solution was cooled to -78 °C and n-BuLi (1.6 M, 0.29 mL, 0.463 mmol) was 
added dropwise. The white suspension was stirred 1h at -78 °C upon which the 
aldehyde (0.024 g, 0.0468 mmol) was added in 2 mL THF. The reaction mixture 
was stirred 1 h -78 °C at which point it was quench ed with saturated ammonium 
chloride and warmed to room temperature. The layers were separated and the 
aqueous layer was extracted with Et2O (3x). The combined organic layers were 
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dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude 
product was purified via flash column chromatography (100% EtOAc to 1% 
MeOH/EtOAc) to provide the product as a pale yellow oil (0.027 g, 90%). 1H 
NMR (400 MHz, CDCl3): δ 0.97 (d, 3H, J = 7.2 Hz), 1.06 (s, 21H), 1.13 (s, 3H), 
1.32 (s, 3H), 1.41 (m, 5H), 1.46-2.08 (bands, 12H), 2.24 (m, 1H), 3.43 (m, 1H), 
3.60-3.72 (bands, 5H), 3.77 (m, 5H), 3.87 (m, 1H), 3.92 (m, 1H), 4.28 (m, 1H), 
4.47 (m, 1H). 13C NMR (100 MHz, CDCl3): δ 12.0, 12.6, 14.3, 18.0, 24.3, 27.4, 
28.9, 29.6, 32.7, 33.9, 34.0, 44.3, 63.4, 70.7, 73.8, 74.1, 74.3, 79.8, 80.2, 81.1, 
83.2, 108.2. IR (film): 3380, 2942, 2896, 2866, 1729, 1463, 1382, 1264, 1171 cm-
1
. ESI-MS: C31H61O9PSi  [M+H] calc. 637.4 , found 637.4, [M+Na] calc. 659.4, 
found 659.4, [M+Cs] calc. 769.3, found 769.3. [α]19D = +15.0° (c = 0.07, CH 2Cl2). 
 
 β-ketophosphonate 68: To a 50 mL round-bottom flask was added the β-
hydroxyphosphonate (0.035 g, 0.0550 mmol) in 4 mL CH2Cl2 (wet). Sodium 
bicarbonate (0.046 g, 0.550 mmol) was added followed by Dess-Martin 
periodinane (0.059 g, 0.138 mmol). The reaction mixture was stirred 30 min at 
room temperature and then quenched with saturated 5:1 Na2S2O3:NaHCO3 and 
stirred 30 min at room temperature. The layers were separated and the aqueous 
layer was extracted with CH2Cl2 (2x). The combined organic layers were dried 
over Na2SO4, filtered, and then concentrated under reduced pressure. The crude 
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product was purified via flash column chromatography (100% EtOAc to 1% 
MeOH/EtOAc) to provide the product as a colorless oil (0.033 g, 94%). 1H NMR 
(400 MHz, CDCl3): δ 0.96 (d, 3H, J = 6.8 Hz), 1.05 (s, 21H), 1.10 (s, 3H), 1.30 (s, 
3H), 1.37 (s, 3H), 1.40-1.70 (bands, 6H), 1.83 (m, 1H), 1.91 (m, 2H), 2.23 (dd, 
1H, J = 6.4 Hz, 13.2 Hz), 2.75 (m, 1H), 2.92 (m, 1H), 3.14 (m, 2H), 3.44 (m, 1H), 
3.65 (bands, 3H), 3.77 (s, 3H), 3.80 (s, 3H), 3.89 (m, 2H), 4.46 (m, 1H). 13C NMR 
(100 MHz, CDCl3): δ 12.0, 12.6, 14.3, 18.0, 24.3, 27.2, 28.9, 29.6, 32.6, 33.6, 
41.8, 43.1, 44.1, 47.8, 53.0, 53.1, 63.4, 70.8, 73.8, 74.3, 77.1, 79.4, 82.8, 108.4, 
200.2. IR (film): 2942, 2892, 2866, 1719, 1463, 1383, 1263, 1212, 1170, 1100 
cm-1. ESI-MS: C31H59O9PSi [M+Na] calc. 657.3, found 657.3, [M+Cs] calc. 767.3, 
found 767.3. [α]20D = 13.4 ° (c = 0.11, CH 2Cl2).  
 
 Enone 67: To a dry 25 mL round-bottom flask, under argon, was added the 
β-ketophosphonate 68 (0.016 g, 0.0245 mmol) in 0.5 mL THF. To the solution 
was added anhydrous barium hydroxide (0.003 g, 0.0187 mmol) and the mixture 
was stirred 30 min at room temperature. Aldehyde 69 (0.012 g, 0.223 mmol) was 
added in 0.30 mL of 40:1 THF:H2O, followed by an additional 0.33 mL of 40:1 
THF:H2O. The reaction mixture was stirred 1 h at room temperature and was 
then diluted with EtOAc and filtered over celite. The solution was washed with 
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saturated sodium bicarbonate and the aqueous layer was extracted with EtOAc 
(4x). The combined organic layers were dried over Na2SO4, filtered, and then 
concentrated under reduced pressure. The crude product was purified via flash 
column chromatography (5% EtOAc/Hex to 10% EtOAc/Hex) to provide the 
product as a colorless oil (0.021 g, 91%). 1H NMR (400 MHz, CDCl3): δ 0.67 (m, 
6H), 1.00 (m, 12H), 1.08 (s, 21H), 1.13 (s, 3H), 1.27 (s, 4H), 1.33 (s, 3H), 1.39 (s, 
3H), 1.41-2.00 (bands, 13H), 2.25 (m, 1H), 2.35 (m, 1H), 2.72-2.87 (bands, 3H), 
3.57 (m, 4H), 3.68 (m, 3H), 3.86 (m, 1H), 3.94 (m, 1H), 4.01 (m, 1H), 4.14 (m, 
1H), 4.41-4.53 (m, 5H), 5.65 (m, 2H), 6.21 (m, 1H), 6.95 (m, 1H), 7.30 (m, 10H). 
13C NMR (100 MHz, CDCl3): δ 5.10, 6.83, 12.1, 12.6, 14.3, 18.0, 20.2, 24.4, 26.7, 
27.4, 29.0, 32.7, 33.7, 37.0, 43.6, 44.3, 63.5, 65.3, 70.2, 70.8, 72.9, 73.4, 74.1, 
74.3, 79.7, 81.1, 82.7, 83.7, 85.3, 108.3, 127.3, 127.4, 127.6, 128.3, 133.1, 
133.5, 136.8, 138.7, 139.1, 144.6, 197.8. IR (film): 2957, 2939, 2869, 2363, 
2340, 1730, 1679, 1463, 1384, 1271, 1103 cm-1. ESI-MS: C61H98O10Si2 [M+H] 
calc. 1047.6, found 1047.6, [M+Na] calc. 1069.6, found 1069.6. [α]19D =  +6.25° (c 
= 0.20, CH2Cl2). 
















































